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Structured Abstract 
Aims 
The aim of this study was to investigate whether transition following successful completion of 
functional appliance therapy was important in retention of the corrected overjet. 
Objectives 
The main objective was to investigate whether a transition phase following successful completion 
of functional appliance therapy was important in retention of the corrected overjet. 
In addition, a secondary objective was to perform a pilot study to aid in a sample size calculation 
for a larger trial to investigate the effect of transition versus no transition following successful 
completion of functional appliance therapy. 
Null Hypothesis 
There is no difference in the effect of a transition phase versus no transition on the corrected 
overjet following successful completion of functional appliance therapy. 
Design 
A single-blind prospective pilot Randomised Control Trial (RCT) to investigate the need for a 
transition phase following successful completion of functional appliance therapy. 
Ethical Approval 
Ethical approval was sought and obtained from the National Research Ethics service (NRES) and 
the NHS Research and Development Offices. This study was given the REC reference number: 
12/NW/0565. 
It was necessary to gain to ethical approval as this was a research project. That meant that it must 
be approved by a formal research ethic committee. In general there is a grey area between audit 
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and research and the distinction is difficult to agree on. This project was thought of as research 
instead of an audit of effectiveness as there was no clinical guidelines or gold standards to make 
a comparison too and therefore less like an audit. The groups were also randomised for differing 
treatment options for patients who were in similar clinical situations and in that case ethical 
approval should be sought. 
Setting 
Patients attending for treatment at the Orthodontic department of the Liverpool University 
Dental and Arrowe Park Hospitals. 
Sample Size 
As this was a pilot study, no sample size calculation had been carried out. The target sample size 
was set at 30, to allow estimation of outcome proportions.  
Participant selection 
Inclusion criteria 
 The subjects entered into the trial would have completed Clark’s Twin Block (CTB) phase 
of treatment and require fixed appliance treatment.   
Exclusion criteria 
 Patients who do not progress into fixed appliance therapy due to low treatment need 
(clinician decision) or low patient interest (patient decision).  
 Patients included in the trial but drop out for any reason, would be included in the 
statistical intention-to-treat analysis (bias reduction). 
 Patients with craniofacial syndromes or clefts of the lip and/or palate. 
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Randomisation 
The randomisation process allocated subjects to the transition or no transition groups. The 
randomisation sequence was generated by a statistician by use of a computer program. The 
statistician was blinded to the recruitment process. The groups were then stratified by the 
Orthodontic Consultant. The treatment allocation was typed onto a card and placed in 
sequentially numbered opaque envelopes. These were kept in the Orthodontic Department 
along with a log of envelope allocation. 
Interventions 
Group A- transition group (standard care) 
Patients undergoing transition by any clinically-based method that was indicated for a period up 
to three months. 
Group B- no transition group (intervention)  
Patients were bonded up with fixed appliances as soon as the CTB phase of treatment was been 
completed. Class 2 mechanics were not immediately applied in the intervention group. This 
followed normal treatment protocol. 
Blinding 
Patients- Aware that they were receiving treatment to correct their malocclusion (not blinded) 
Clinicians- Aware of whether or not a transition phase was being used to maintain the overjet 
correction (not blinded) 
Assessors- Unaware measurements carried out clinically (blinded) 
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Method 
Patients were randomly allocated to either Group A (Standard care) or Group B (intervention). 
They were then followed up monthly for a period of three months. At each monthly visit, clinical 
measurements of overjet were taken. At the end of this period the clinical measurements were 
analysed by a blinded assessor who was unaware of the allocation of the treatment. 
Outcome measures 
The primary outcome variable was the presence/absence of a corrected overjet at the end of the 
study within 2mm of the overjet at the end of Twin Block therapy.  
The overjet measurements were based on clinical findings. 
Statistical analysis 
Data was transferred from the data collection forms on a Microsoft© Excel spreadsheet and 
SPSS© software was used for the statistical analysis. 
As a pilot, efficacy testing was not one of the primary aims of this study, as the study was not 
powered to detect a difference. However, a statistical analysis of the primary outcome data was 
be carried out, using Fisher’s exact test to compare the proportions with retention of the 
corrected overjet at the end of the trial.  
The primary outcome was retention of the corrected overjet. 
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Results 
 The recruited sample was primarily female at 66.6% compared to males at 33.3%. Females 
were shown to have a higher success rate than males at 80%; however these results were 
not significant. 
 The average overjet in Group A was 7.1 mm. The average overjet of the successful 
patients in Group A was 7.3 mm and 7 mm in the unsuccessful patients.  
 The average overjet in Group B was 10.5 mm. The average overjet in the successful 
patients in Group B was 11.3 mm and 9.3 mm in the unsuccessful patients.  
 In Group A, 1 successful and 1 unsuccessful patient attended the casuals’ clinic. In Group 
B, 3 successful and 1 unsuccessful patients attended the casuals’ clinic. 
 In the total sample only 1 patient cancelled an appointment, this appointment was 
subsequently rearranged for within 2 weeks of original date. 
 In the total sample only 1 patient failed to attend an appointment. 
 All patients in the study had a Dental Health Component (DHC) of either a 4a or 5a. 33.3% 
had a DHC component of a 5a and 66.66% had a 4a. 
 A Fisher’s exact test was carried out to compare the proportions with retention of the 
corrected overjet. The p value was 0.643 (Appendix 1) which was substantially higher than 
the 0.05 level of statistical significance set for this study. 
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Conclusion 
1. The null hypothesis could not be rejected based on the results of this study. Therefore, there 
is no evidence of difference in using any form of transition following successful completion 
of functional appliance therapy compared to no transition. 
2. A secondary objective of this study was to investigate the size of sample size needed to 
appropriately power a project of this type. This was measured to 97 patients per group with 
α set at 80% and significance level of 0.05. 
3. Due to the small sample size, the study was not powered to detect a clinical significance 
difference between the groups and therefore it is not possible to determine if the 
intervention is better at maintaining the control group than the standard care group 
4. This pilot did not give sufficient information to accurately estimate the proportion of 
successful retention of the overjet in the transition group. 
5. The investigation was not continued after the doctoral project was complete due to 
problems with recruitment and lack of personnel to continue the study. 
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1.0 Literature Review  
1.1 Introduction 
Functional appliance therapy is the mainstay of orthodontic treatment aimed at the reduction of 
an increased overjet often found in association with Class II malocclusion in the growing patient. 
It has long been debated whether there is a need for a transition period following the use of 
functional appliances or if progression into the fixed appliance phase can be implemented 
without a relapse of the corrected overjet in the treatment of Class II malocclusion. The most 
popular functional appliance in use in the United Kingdom (UK) today is the modified Clark’s Twin 
Block (CTB) (Clark, 1988). 
The need for appliance transition following an active phase of functional appliance therapy has 
become evident in certain instances where a return of the original malocclusion features has 
been observed. The most prominent aspect of those features has been an increased overjet. This, 
in turn, could potentially lead to a need for tooth extraction in the maxillary arch to re-establish 
the corrected overjet. There are a number of methods commonly used in clinical orthodontics to 
carry out the transition phase (Fleming et al., 2007). These may range from nocturnal appliance 
wear, trimming of the occlusal surfaces of the lower blocks to facilitate closure of lateral open 
bites, construction of an Upper Removable Appliance (URA) with a steep incline bite plane or 
immediate progression into fixed orthodontic appliances with early use of inter-maxillary traction 
(Class II traction). The alternative would be the cessation of the functional appliance wear in 
order to evaluate the potential relapse prior to fixed appliance treatment progression. 
Elimination of the transition phase could precipitate into several advantages. Primarily, it would 
reduce treatment time by approximately three months, with obvious implications in reduction of 
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clinical time and treatment cost. In addition, there have been suggestions in the literature that 
shorter treatment duration is associated with improved patient compliance with treatment 
(Royko et al., 1999). The focus of functional appliance treatment in the literature has been 
predominantly concerned with the mode of action of functional appliances (Dermaut & Aelbers, 
1996). On the other hand there is a paucity of evidence regarding the appropriateness of the 
transition stage. This research could potentially fill in a void in the understanding of a mode of 
treatment that is in use by orthodontist worldwide.  
1.2 History of functional appliance treatment 
One of the earliest designs of a type of functional appliance was by Norman Kingsley, who created 
an upper removable appliance with the following components;  
1. molar clips 
2. continuous labial wire 
3. posterior bite blocks 
The proposed use of this appliance was to posture the mandible forward. Wahl (1996) reviewed 
the history of functional appliances quoting Norman Kingsley (1879) ‘The object was not to 
protrude the lower teeth, but to change or jump the bite in case of an excessively retreating 
lower jaw’. This could be considered to be the forefather of modern day functional appliances. 
In the United States of America (USA), Edward Angle (1907) used a fixed type of functional 
appliance with interlocking rings on first molar bands to posture the mandible forward. 
 Pierre Robin (1902) was another pioneer of functional appliances. His proposed design 
supposedly stretched the facial muscles by altering the sagittal relationship of the maxilla to the 
mandible. This monobloc appliance was an adaption of Kingsley’s maxillary plate (Kingsley, 1880). 
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The appliance extended across the lingual surfaces of the mandibular teeth as well as lingual 
indentations of both maxillary and mandibular teeth. Furthermore, it incorporated an expansion 
screw to allow transverse expansion of the maxillary arch. The original purpose of this appliance 
was to suit children with glossoptosis syndrome recently re-named Pierre Robin syndrome. The 
appliance acted as a passive positioning device for patients with a micrognathic mandible and 
posterior position of the tongue, which could potentially obstruct the airway. 
This idea was further developed by Viggo Andresen in (1909), who designed the Activator, which 
was a tooth-borne, loose fitting passive appliance. The original design featured facets that 
directed erupting posterior teeth mesially (mandible) or distally (maxilla). He proposed the 
appliance had a loose fit in the mouth and therefore it transferred the stimuli from the teeth to 
the supporting muscular structures. It was a controversial appliance which was further developed 
and refined and eventually became an extremely popular appliance in Europe.  
Another early user of functional appliances was Emil Herbst (1905) coining the synonymous 
appliance. This was a fixed functional design and thought suitable for older children who, 
potentially, could not tolerate a removable appliance. The appliance consisted of a telescopic 
arm that was attached to the maxillary first molars and a cantilever connection attached to the 
mandibular first molars. This appliance was not widely used until Hans Pancherz revived interest 
for it in the 1970’s (Pancherz, 1979). 
In 1956, Martin Schwartz attempted a combination of the activator and the active plate by 
constructing separate mandibular and maxillary components that were designed to posture the 
mandible forward. This appliance echoed the design of half a century earlier by Pierre Robin. 
Another appliance was the Bionator designed by Wilhelm Balters (Balters 1964, 1969) which was 
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a modification of the Andreessen Activator. 
In 1966 Rolf Frankel, created an appliance that was entirely mucosa borne. He proposed that the 
corrected malocclusion will remain stable if the structural and functional deviations of the 
muscular system are corrected. He created three appliances, the Functional Regulator I, II and III 
for treating Class I, Class II and Class III malocclusions respectively (Frankel, 1966). This was 
received well in the USA eventually becoming a popular appliance at that time. 
In 1977, William Clark designed the modern day functional appliance that became the Twin Block 
(Clark, 1988). It is presently the most commonly used functional appliance in the UK. The CTB is 
a development of Pierre Robin’s monobloc and Schwarz’s double plate. It consisted of upper and 
lower bite blocks interlocking at an angle of 45°. The bite blocks were set at 5-6 mm thick in the 
premolar region with 1-2 mm in the molar region in order to allow eruption of the lower molar 
segments. The original design incorporated the use of a Concorde facial bow for extra oral 
traction as this was thought to be of use in high angle patients. 
1.3 The use of functional appliances in contemporary Orthodontic treatment 
The most popular functional appliance in use in the UK today is the modified CTB (Chadwick et 
al., 1998). The CTB appliance achieves its effects through forces arising from the masticatory and 
facial muscles (Fleming et al., 2007; Ghafari et al., 1998). It is commonly used to treat Class II or 
in certain instances Class III malocclusions (Seehra et al., 2010). Functional appliances are often 
used in the younger age groups during the growth spurt. The other clinical indications for a 
functional appliance include anchorage demanding crowded Class II cases. They can also be used 
as an early intervention appliance in the mixed dentition as well or a compliance ‘tester’. Lastly 
it can also be used in the instances that oral hygiene is not at the standard required for fixed 
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appliance treatment. 
1.4 Mode of action of functional treatment 
There has been a significant amount of controversy regarding the mode of action of functional 
appliances. Some workers have claimed that skeletal growth of the mandible was feasible. These 
claims were scientifically unsubstantiated and remain largely unproven. Another body of 
evidence has suggested that the mode of action is mostly dento-alveolar (O’Brien et al.; 2003, 
Ghafari et al.; 1998, Keeling et al.; 1998, Tulloch et al.; 1997). 
The body of evidence is divided into animal laboratory studies and human RCTs or well controlled 
cephalometric based studies. 
1.4.1 Animal studies 
 Woodside (1987) using cappucian monkeys experimented with the Herbst appliance. The results 
of this study showed the mandible did move forward into a more anterior position. The study 
also showed that an element of normal growth was present, attributing some of the correction 
seen. Furthermore there was extensive glenoid fossa remodelling on the treated subjects. This 
study however suffered from lack of adequate controls.  
Studies carried out by Woodside (1987) on rats suggested that functional appliances cause lateral 
pterygoid muscle stretching, stimulation of growth factors and promoting condylar growth. 
There was also a suggestion of remodelling of the glenoid fossa.  
Dermaut and Aelbers (1996) carried out a study using various animal models. Their study showed 
cartilage proliferation in the pre-chondroblastic zone. It suggested an increase in the effective 
length of the mandible and remodelling of the glenoid fossa as well as maxillary restraint with 
extra oral traction. Similarly, glenoid fossa remodelling was a common finding. The limitations of 
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study were a small sample size and an artificially introduced skeletal discrepancy.  
The Petrovic et al (1979) study suggested that anterior posturing of the mandible in growing rats 
can precipitate additional growth of the condylar cartilage causing an increase in mandibular 
growth by stimulating the cells in the proliferation zone. Another study by Tsolakis et al (1997) 
reported an increase in the mandibular length.  
More recently Rabie et al (2003) investigated an alteration of gene expression in rats that had 
been treated with a functional appliance. This study showed that a transcription factor, SOX-9, 
that targeted type II collagen, was up regulated in the glenoid fossa following mandibular 
posturing. This also induced cell signalling molecules in the proliferation zone of the cartilage. All 
of these findings have been interpreted as evidence that functional appliances enhance condylar 
growth. This was only a transient effect as no long term follow up was carried out. 
The evidence in the literature has shown that posturing of the mandible in animal models can 
cause an alteration in the surface contours of the condyle, glenoid fossa and posterior glenoid 
tubercle. Furthermore, condylar growth can be directed in a more posterior direction as well as 
stimulate growth factors and alter gene expression. However, the results cannot be extrapolated 
to human treatment easily. The main problems with this type of research were:  
1. Small sample size  
2. Poor long term follow up  
3. No element of compliance 
4. Artificially induced malocclusions 
In contrast there has been an extensive body of evidence regarding human research that perhaps 
is more applicable to clinical orthodontics. 
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1.4.2 Human studies 
There have been a number of clinical Trials carried out investigating the effect of functional 
mandibular growth. In general they all have shown small differences in the mandibular length of 
the passive tooth borne appliances. 
Ruf and Pancherz (1998) carried out a study to investigate the effect of the Herbst appliance on 
the glenoid fossa and the condyle. They used Magnetic Resonance Imaging (MRI) was used to 
assess the TMJ anatomy. The results showed condyle and glenoid fossa remodelling. 
Dermaut and Aelbers (1996) in their review of the literature had stated a number of findings, 
1. Different response of males and females to treatment 
2. Inhibition of maxillary growth was seen in 33% of activator or Herbst studies 
3. Mandibular growth was affected in 68% of Herbst and Activator studies 
4. The Herbst appliance showed a mean reduction in ANB of 3.5 and increased mandibular 
length (Co-Gn) of 4 mm. 
5. Maxillary length changes never exceeded 1 mm 
6. Negligible changes in palatal plane 
This study highlighted that with the Herbst appliance by Ruf and Pancherz (1998) lacked long 
term follow up to substantiate the proposed long term effects of the appliance. 
Another study by Sandler and Lund (1998) further reinforces that the effects of the functional 
appliance were dento-alveolar rather than skeletal. The study reported statistically significant 
results in relation to the following 
1. Reduction of ANB of 2 
2. Increase in SNB of 1.9 
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3. Increase of Ar-Pog compared to control 
4. Maxillary incisor retroclination of 10.8° 
5. Mandibular incisor proclination of 7.9° 
They concluded that the overjet was reduced by the forward movement of the mandible. The 
buccal segments were corrected by lower molar eruption and the restraint of maxillary molars 
eruption. They also concluded that the main contributing factor in reducing the overjet was the 
effect that the appliance had on the dento-alveolar structures. 
Chen et al (2002) carried out an analysis of the efficacy of functional appliances on mandibular 
growth. This was a meta-analysis concluding that there was no evidence to suggest a change in 
the mandibular length. 
In conclusion, the current concepts that are widely accepted for the mode of action of functional 
appliances are; 
1. Dento-alveolar changes causing the maxillary teeth to move more posteriorly and the 
mandibular teeth anteriorly 
2. A  restriction  of the maxillary growth  
3. Very little evidence of permanent mandibular growth 
4. Glenoid  fossa remodelling causing forward positioning of the condyle 
As with animal studies, human studies also have their drawbacks, this is because a large number 
of the human studies have used cephalometric measurements taken from lateral cephalogram 
radiographs, where a chance of error in measurements exists (Baumrind and Frantz, 1971). The 
control groups can be difficult to match as it is unethical to withhold treatment if deemed 
clinically necessary. Overall, as with most dental/orthodontic studies they suffer from a small 
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sample size. 
1.5 Timing of functional appliance treatment 
As with all areas of research related to functional appliance treatment, treatment timing has 
been another controversial field. There is various different treatment approaches centred round 
one or two phase treatment plans. One of the common ways to treat the Class II malocclusion 
involves a functional appliance at age range 7-10 years old. At the conclusion of the first phase 
of treatment fixed appliances would be utilised. The delay would be due to the anticipation of 
the establishment of the permanent dentition. This method of treatment potentially is limiting 
since the patients experience a longer course of treatment. Another limiting factor may be a 
longer period of retention in order to maintain the corrected overjet. The alternative would be 
to provide a single or one phase course of treatment. Conversely this is achieved by progressing 
to fixed appliances at the conclusion of the functional appliance treatment. 
The available scientific evidence from RCT’s in the USA and United Kingdom (UK), have attempted 
to shed light on treatment timing. 
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Table 1 illustrates the main findings of studies on functional appliances. 
Authors Year Appliance Summary of results 
Tulloch 
et al 
1997 
Bionator appliance and 
extra oral traction 
Variation of growth whether or not treatment 
was carried out ( 31% controls had favourable 
growth improvements) 
Early treatment group had initial skeletal 
change but and end of phase 2 of treatment no 
difference when compared to the late 
treatment group 
No difference in PAR score between early and 
late treatment scores 
Early treatment group in fixed appliance for 
shorter time (only approached significant) 
Percentage going onto surgery similar 
Percentage having extractions not significant 
but approached significance for early treatment 
having more extractions 
Keeling 
et al 
1998 
Bionator appliance and 
extra oral traction with 
URA with bite plane 
Extra oral traction and Bionator do not affect 
maxillary growth in 9-10 year old patients 
Both appliances enhance mandibular growth 
Skeletal changes achieved are stable 
No difference between early and late treatment 
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groups at end of phase two 
Ghafari 
et al 
1998 
Frankel appliance and 
extra oral traction 
Both effective at treating Class II division 1 
malocclusions 
Timing not critical leave till late childhood 
Extra oral traction greater effect on the molars 
Frankel had greater overjet reduction 
Compliance poor with the appliance 
Fig 1. Landmark studies on the mode of action of functional appliances with a summary of the main results. 
 
Since the O’Brien (2003) study was conducted in the United Kingdom (UK), it has been suggested 
that it is most relative to treatment provided in the UK. The second part of the study related the 
physical effect to the psychosocial influence of treatment. They concluded that the overjet 
reduction was due to dento-alveolar effects with minimal influence to the skeletal bases. The 
second part of the study found that treating patients at a younger age could improve self-concept 
with less negative social experiences.  
1.6 The modified Clark’s Twin Block 
In 1977, William Clark designed functional appliance that is the Twin Block (Clark, 1988). Its 
modification has become the most commonly used functional appliance in the UK (Chadwick et 
al., 1998). The modified CTB that is currently used consists of upper and lower bite blocks which 
interlock at an angle of 45°. He originally suggested that the bite blocks were to be of 5-6 mm 
thick in the pre molar region and 1-2 mm in the molar region to allow eruption of the molar 
segments. Retention was provided by modified double arrowhead clasps that usually spanned 
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two buccal teeth and with a tube soldered onto the clasp for the attachment of extra-oral 
traction. The other features of the upper appliance included a midline expansion screw and a 
labial bow that extended from one upper first permanent molar to the other. The lower appliance 
was retained in the permanent dentition by inter-dental clasps in the incisor and premolar region. 
A reverse ‘U’ loop was placed lingually to the lower central incisors to allow the attachment of 
inter-maxillary traction. It was also stated that the bite blocks should only cover the palatal cusps 
of the upper maxillary cusps to improve retention. A Concorde face bow was to be worn 
simultaneously with the appliance. The Concorde face bow had similar design features to other 
forms of extra oral traction with the addition of a midline labial hook to allow the use of inter 
maxillary traction. There have been several modifications by the author ever since. In the lower 
appliance, the reverse ‘U’ loop and inter- dental clasps in the premolar region were removed and 
replaced by ball ended clasps for retention in the incisor region. For retention in the premolar 
region delta clasps were introduced.  
The designs that currently are in use stem from this original design. The upper appliance uses 
Adams cribs for retention and a labial bow. The Concorde bow is not usually used. In the lower 
arch the Delta clasps have been replaced by Adams clasps. 
1.7 Transition phase- Progression into fixed orthodontic appliances 
Current literature contains limited number of articles relating to the transition from functional 
appliance to fixed appliance treatment. A clinical overview was written by Fleming, Scott and 
DiBiase (2007) on how to manage the transition phase. They suggested that correction must be 
maintained during the aligning and levelling stages until stainless steel arch wires and Class II 
traction can be utilised. The relapse in the transition stage could be postural with repositioning 
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of the mandibular condyle and uprighting of the distally tipped maxillary dentition. The key in 
preventing relapse is appropriate management of these factors in the transition stage and early 
phases of fixed appliance treatment. The paper suggested that overcorrection of the overjet 
resulting in an edge to edge or Class III incisor relationship and molar relationship could be 
desirable.  
Extra oral traction could be advantageous in maintenance of the overjet correction and molar 
relationship and it allows the clinician to proceed directly into fixed appliances. Lastly extra oral 
traction could be introduced on the withdrawal of the functional appliance and worn during the 
aligning and levelling stages and can be withdrawn when in a stainless steel archwire. The biggest 
disadvantage in using extra oral traction would be the reduction of compliance of the patient. 
Another method of transition is nocturnal use of the appliance. Some clinicians prefer the patient 
to wear the appliance at night-time only as it is thought to maintain the neuromusculatory 
response and remodelling effects of the condyle (Fleming et al., 1997). It is thought to help 
maintain the overjet correction and molar relationship and the appliance could be modified to 
allow fixed appliances to be placed at the same time.  
Another method of maintain the correction is with an appliance termed ‘Steep and Deep’ 
(Sandler and DiBiase, 1996).  This is a removable appliance with an inclined bite plane that is worn 
continuously and can also be altered to be used concurrently with fixed appliances.  A bite plane 
of at least 8 mm deep and at an inclination of 70 degrees to the horizontal has been described 
(Sandler and DiBiase, 1996). This appliance is useful as it allows the closure of lateral open bite 
whilst still maintaining the Class II effect. The use of the steep and deep appliance has its 
limitations as it can cause proclination of the lower labial segment and it has to be of sufficient 
24 
 
depth to allow occlusion anterior to the bite plane to prohibit a relapse in the corrected overjet. 
In theory it could cause differential eruption of the second molars resulting in increased vertical 
dimension in high angle cases. 
Another method would be progression into fixed appliance with early use of Class II inter 
maxillary traction (Fleming et al., 1997). The disadvantage of inter maxillary elastics is that it could 
potentially further procline the lower incisors as well as downward and backward rotate the 
mandible and lingually tip the lower molars. 
1.8 Conclusion 
There is a trend amongst all the literature of an air of uncertainty to the mode of action of these 
appliances with contrasting opinions and scientific evidence. It is clear that there is still a 
potential to learn more in this area and hopefully the future will bring definitive answers to the 
questions that we pose. It is hoped that this research study will bring about some concrete 
evidence that will be a starter point for further investigations. 
1.9 Rationale for research 
After searching through the literature in this area, it was apparent that there was a paucity of 
research into the transitional stage of twin-block appliance therapy. There is no evidence to base 
a clinical decision on when to proceed to the transition stage or if this stage is even necessary. 
There have never been any clinical Trials investigating if this area and this is why that I have 
decided on this area for research. 
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2.0 Study: Aims and Objectives 
2.1 Aims 
The aim of this study was to investigate whether transition following successful completion of 
functional appliance therapy was important in retention of the corrected overjet. 
2.2 Objectives 
The main objective was to investigate whether a transition phase following successful completion 
of functional appliance therapy is important in retention of the corrected overjet. 
In addition, a secondary objective was to perform a pilot study to aid in a sample size calculation 
for a larger trial to investigate the effect of transition versus no transition following successful 
completion of functional appliance therapy. 
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3.0 Null Hypothesis 
There is no difference in the effect of transition versus no transition following successful 
completion of the functional appliance therapy on the corrected overjet. 
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4.0 Materials and Methods 
4.1 Ethical approval 
Ethical approval was sought and obtained from the National Research Ethics service (NRES) and 
the NHS Research and Development Offices. This study was given the REC reference number: 
12/NW/0565. 
4.2 Study Design 
4.2.1 Inclusion criteria 
 The subjects entered into the trial would have completed Clark’s Twin Block (CTB) phase 
of treatment and require fixed appliance treatment.   
4.2.2 Exclusion criteria 
 Patients who do not progress into fixed appliance therapy due to low treatment need 
(clinician decision) or low patient interest (patient decision).  
 Patients included in the trial but drop out for any reason, would be included in the 
statistical intention-to-treat analysis (bias reduction). 
 Patients with craniofacial syndromes or clefts of the lip and/or palate. 
4.3 Recruitment 
Patients were invited to participate if they fulfilled the inclusion criteria. They were recruited 
from patients attending for treatment at the Orthodontic department of the Liverpool University 
Dental and Arrowe Park Hospitals. 
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4.4 Randomisation 
The randomisation process allocated subjects to the transition or no transition groups. The 
randomisation sequence was generated by a statistician by use of a computer program. The 
statistician was blinded to the recruitment process. The groups were then stratified by the 
Orthodontic Consultant. The treatment allocation was typed onto a card and placed in 
sequentially numbered opaque envelopes. These were kept in the Orthodontic department along 
with a log of envelope allocation. 
4.5 Blinding 
Patients- Aware that they were receiving treatment to correct their malocclusion (not blinded). 
Clinicians- Aware whether or not a transition phase is being used to maintain the overjet 
correction (not blinded). 
Assessors- Unaware measurements carried out clinically (blinded). 
4.6 Consent 
Written informed consent was obtained from the parents of the children who participated in the 
study and for the intended treatment. A separate written consent was obtained from the patients 
(Appendix 10.1 and 10.2). 
At the first appointment, all eligible patients and their parents had the study explained to them 
verbally and were invited to ask any questions that may have arisen. They were given all the 
relevant patient information leaflets. The patient was then given a review appointment. 
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At the second appointment, another opportunity was given for the patients to ask any questions 
that the patient information leaflet brought to light. They then confirmed their participation in 
the study. Written informed consent was obtained from all the patients entered into the trial. 
4.7 Sample size 
As this was a pilot study, no sample size calculation had been carried out. The target sample size 
was set at 30, to allow estimation of outcome proportions.  
4.8 Treatment 
Treatment was carried out by post-graduate students in Orthodontics at the Orthodontic 
Departments of the Liverpool University Dental Hospital and Arrowe Park Hospital. An official 
brief on the study and the protocol for the accepted patients was circulated to clinical and nursing 
staff. 
Patients fulfilling the inclusion criteria were invited to participate. 
Group A- transition group (standard care) 
Patients underwent transition by any clinically-based method that was indicated for a period up 
to three months. 
Group B- no transition group (intervention)  
Patients were bonded up with fixed appliances as soon as the functional phase of treatment was 
been completed.  
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4.9 Protocol Deviation 
At any point the patient was free to withdraw their consent. 
There was a standard departmental wide protocol for patients who Failed To Attend (FTA). 
1st FTA - another appointment was sent out in the post and logged into the notes. 
2nd FTA- a letter was sent out asking the patient to contact the department to make another 
appointment. If there is no contact within 2 weeks then a phone call to the patient was made. 
3rd FTA- Patient was contacted directly by phone asking them to come into the department. They 
were asked if they wished to continue treatment and emphasised the importance of keeping 
their appointments. 
4.10 Unable to Attend (UTA) protocol 
Patients were to be contacted to make another appointment by either telephone or by sending 
a new appointment out to them. 
4.11 Casualty protocol 
Patients were given information to contact the department if any breakages/problems arose with 
the treatment. It will not be possible for a single operator to treat all the patients that present 
with breakages during the trial due to the number of patients involved. However the 
department’s casual protocols were followed. 
4.12 Breakages protocol 
In the event of a breakage, the patient would be seen at the same day. If the circumstances did 
not permit this, it would be endeavoured to see the patients as soon as possible. 
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4.13 Patients who fail to complete the trial 
If any patients withdraw their consent then it may not be possible to include them in the final 
statistical analysis. 
4.14 Assessment of patient response 
The primary outcome variable was the presence/absence of a corrected overjet at the end of the 
trial within 2 mm of the overjet at the end of Twin Block therapy. The overjet measurements 
were based on clinical findings. 
4.15 Data collection 
Baseline data for both treatment groups included the following: 
Clinical measurements: Overjet, overbite, molar relationship, canine relationship and dental 
centrelines. 
Data collected on the patient’s medical, social and dental history, their skeletal pattern, dental 
health, occlusal and TMJ status. This data were stored as linked anonymised data. 
In addition, the number of failed appointments, cancelled appointments, number of visits to the 
casual’s clinic and the total overall number of appointments were recorded. 
The Index of Orthodontic Treatment Need (IOTN) was calculated on the Angle-trimmed study 
plaster models.  
The trial started when the patient was deemed ready to proceed into the transition stage. This 
was when the patient had an overjet of between 0 and 4 mm.  
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 Data collection point 1 (start point) – at end of Twin Block therapy: Clinical 
measurements  
 Data collection point 2 (end point) – following three months: Clinical measurements  
4.16 Data storage 
Data were entered on specifically designed data collection forms in addition to being entered 
into the patients’ medical notes .The forms were in the medical notes and removed when 
collating the data into a secure filing cabinet.  
The model boxes were stored as per normal departmental protocol within a secure area within 
the department.  
The radiographs were stored in the patients’ cases notes in their radiographic folder or on the 
online server (digital). 
The patients’ ID numbers recording the randomisation method were kept in a separate envelope. 
The data was transferred onto a computer database and backed up on Trust-approved encrypted 
and password protected memory sticks. 
The information collected was stored as linked anonymised data. 
4.17 Statistical analysis 
Data was transferred from the data collection forms on a Microsoft© Excel spreadsheet and 
SPSS© software was used for the statistical analysis. 
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As a pilot, efficacy testing was not one of the primary aims of this study, as the study was not 
powered to detect a difference. However, a statistical analysis of the primary outcome data was 
be carried out, using Fisher’s exact test to compare the proportions with retention of the 
corrected overjet at the end of the study.  
The primary outcome was retention of the corrected overjet. 
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5.0 Results 
 
5.1 Recruitment Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Recruitment flow chart. 
 
Assessed for eligibility (n= 9) 
Excluded (n=0) 
   Not meeting inclusion criteria (n=0) 
   Declined to participate (n= 0) 
   Other reasons (n=0) 
Analysed (n= 4)  
 Excluded from analysis (n=0) 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Allocated to Standard care group A (n=4) 
 Received allocated intervention (n=4) 
 Did not receive allocated intervention (n=0) 
Lost to follow-up (n= 0) 
Discontinued intervention (n=0) 
Allocated to Intervention group B (n=5) 
 Received allocated intervention (n= 5) 
 Did not receive allocated intervention (n=0) 
Analysed (n= 5)  
 Excluded from analysis (n=0) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n= 9) 
Enrolment 
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5.2 Interpretation of the flow diagram 
During the period of recruitment from 1/10/2012 until 30/4/2013, 9 patients were enrolled into 
the trial. There was a 3-month follow up of the patients from the date that they entered into it.  
From the flow chart it can be seen that 9 patients were suitable for recruitment. They were 
randomly assigned to each group by the aforementioned randomisation process, involving a 
statistician who by the use of a computer program generated the allocations. These were then 
typed onto a card and placed in sequentially numbered opaque envelopes. When a patient was 
recruited into the trial, the first envelope was then collected. 
Four patients were randomly allocated to the Transition Group A (standard care) and five were 
randomly allocated to the No Transition Group B (intervention). There were no patients declined 
to participate or dropped out during the study period. All patients were followed up and included 
in the statistical analysis and examined in original randomly allocated groups. 
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5.3 Sample Characteristics 
 Group A Group B Total 
N 4 5 9 
    
Gender (%) 
Male 
Female 
 
2 (50) 
2 (50) 
 
1 (20) 
4 (80) 
 
3 (33.33) 
6 (66.66) 
    
Mean average overjet 
in mm (s.d.) 
7.1 (0.85) 10.5 (3) 8.8 (2.82) 
    
Pre-treatment overjet 
(mm) 
≥ 15 
12-14 
10-12 
8-10 
6-8 
 
 
0 
0 
0 
1 
3 
 
 
1 
0 
2 
1 
1 
 
 
1 
0 
2 
2 
4 
IOTN (DHC) 
5a 
4a 
 
0 
4 
 
3 
2 
 
3 
6 
Table 1- Sample characteristics 
5.3.1 Gender 
The recruited sample was primarily female at 66.6% compared to males at 33.3% (table 1). In 
Group A there was even distribution of males and females (table 1). In Group B, it was 
predominantly females at 80%. 
5.3.2 Pre-treatment overjet 
The average overjet in Group A was 7.1 mm and the average overjet in Group B was 10.5mm 
(table 1).  
The majority of the total sample, 8 patients (89%) had an overjet within 6-12 mm. There was only 
1 patient (11%) who had an overjet of 15 mm or above. 
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In Group A all the patients had an overjet within 6-10 mm; where as in Group B 3 patients (60%) 
had an overjet over 10 mm. 
5.3.3 Casuals appointments, Unable to attend (UTA) and failure to attend (FTA) (Secondary 
outcomes) 
Table 2 
 Group A Group B Total 
N 4 5 9 
    
Casuals appointments 2 4 6 
    
Unable to attend (UTA) 0 1 1 
    
Failure to attends (FTA) 1 0 1 
Table 2 – secondary outcome results 
Casual appointments 
In the total sample there were 6 patients who attended an extra casual appointment out with 
their routine appointment (table 2). The reasons cited for attending these appointments were 
commonly an orthodontic bracket that had debonded, a piece of wire causing mucosal trauma 
and the functional appliance not fitting properly. 
UTAs 
In the total sample only 1 patient cancelled an appointment, this appointment was subsequently 
rearranged for within 2 weeks of original date (table 1). 
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FTAs 
In the total sample only 1 patient failed to attend an appointment. The patient was then sent out 
another appointment following the protocol. The patient cited that they forgot about the 
appointment as the reasons for failing to attend the routine appointment. The patient was 
accommodated within 2 weeks of original appointment. 
5.3.4 IOTN (Brook and Shaw, 1989) 
All patients had a Dental Health Component (DHC) of either a 4a or 5a. A 4a is an overjet of 6.1 
mm or above but less than 9mm and a 5a is an overjet greater than or equal to 9 mm. 
In group A, all patients fell into the 4a category (table 1). In group B, two patients had a 4a and 
three had a 5a (Table1). 
Overall, 33.3% of the sample was a 5a and 66.66% was a 4a. 
5.4 Primary outcome data 
The primary outcome of the study is the presence or absence of a corrected overjet at the end 
of the trial. 
 Group A Group B Total 
Successful 2 (50%) 3 (60%) 5 (55.6%) 
Unsuccessful 2 (50%) 2 (40%) 4 (44.4%) 
Total 4 (100%) 5 (100%) 9 (100%) 
Table 3- primary outcome data 
The results show that in total from both groups, 5 patients (55.6%) were successful in maintaining 
the corrected overjet after the functional appliance therapy. 
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In group A, both the number of patients who succeeded and the number of patients who did not 
succeed were equal.  
In group B, 3 (60%) patients were successful in maintaining the corrected overjet after the 
functional appliance therapy and 2 (40%) were not successful. 
A Fisher’s exact test was carried out to compare the proportions with retention of the corrected 
overjet. The p value was 0.643 (Appendix 1) which was substantially higher than the 0.05 level of 
statistical significance set for this study. 
Harms or unintended effects  
During this trial there were no harms or unintended effects that could have caused it to be 
discontinued. 
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5.5 Comparison of primary outcome data with secondary outcomes 
 Group A Group B 
N unsuccessful successful unsuccessful successful 
 
Primary outcome (%) 2 (50) 2 (50) 2 (40) 3 (60) 
   
Gender (%) 
Male 
Female 
 
2 (100) 
0 (0) 
 
0 (0) 
2 (100) 
 
0 (0) 
2 (100) 
 
1 (33.33) 
2 (66.66) 
   
Mean overjet in mm (s.d.) 7.3 (1.41) 7.0 (0.35) 9.3 (2.47) 11.3 (3.51) 
 
Pre-treatment overjet (mm) 
 
≥ 15 
12-14 
10-12 
8-10 
6-8 
 
 
0 
0 
0 
0 
2 
 
 
0 
0 
0 
1 
1 
 
 
0 
0 
1 
0 
1 
 
 
1 
0 
1 
1 
0 
Casuals 1 1 1 3 
Unable to attend (UTAs) 0 0 0 1 
Failure to attend (FTAs) 0 1 0 0 
Table 4-comparison of primary outcome with secondary outcomes 
Gender 
Females were shown to have a higher success rate than males with four females being successful 
across both groups compared to one male. 
The patients that were successful in Group A were all female and in Group B 2/3 of the successful 
patients were female. The patients that were unsuccessful in Group A were male and in Group A 
were female. 
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Pre-treatment overjet 
The average overjet of the successful patients in Group A was 7.3 mm and 7 mm in the 
unsuccessful patients. The average overjet of the successful patients in Group B was 11.3 mm 
and 9.3 mm in the unsuccessful patients. 
In Group A all the successful patients had an overjet between 6-8 mm and the unsuccessful 
patients had an overjet between 6-10 mm. 
In Group B there was a wider variability of overjet in the successful patients, with overjet values 
ranging from 8 mm to greater than 15 mm. In the unsuccessful patients in Group B the range was 
between 6-12 mm. 
Casual appointments 
In Group A, 1 successful and 1 unsuccessful patient attended the casuals’ clinic. In Group B, 3 
successful and 1 unsuccessful patients attended the casuals’ clinic. 
UTAs 
One patient in study cancelled an appointment and this was subsequently rearranged. They were 
a successful patient in Group B. 
FTAs 
One patient in study failed to attend an appointment and this was subsequently rearranged. They 
were a successful patient in Group A. 
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6.0 Discussion 
6.1 Introduction 
The first recorded Randomised Controlled Trial (RCT) was published only 50 years ago (Medical 
Research Council, 1948). Pioneered by the statistician Austin Bradford Hill, he managed to 
persuade a number of doctors to randomly allocate patients with Tuberculosis to either 
streptomycin or no treatment. It was partly thought up to conserve the small supply of the 
antibiotic streptomycin and to find out if this line of treatment actually was effective against 
tuberculosis.  
Randomised Controlled Trials are one of the simplest, most powerful and revolutionary tools of 
research (Jadad and Rennie, 1998; Schlutz et al., 1995). An RCT in simple terms is a type of clinical 
study whereby participants are randomly allocated into groups of several clinical interventions. 
It can be used to evaluate a therapeutic intervention, whether it is old and never been tested or 
new and never been clinically evaluated. This then allows comparisons to be made of the 
differences, if any between the groups studied after the patients receive the intervention. The 
groups of patients should have similar baseline characteristics, in order for any change between 
the groups to either be by chance or due to one of the interventions that a particular group 
received. The gold standard way of allocating these patients to the groups is by random 
allocation. This means that all the participants have the same chance of entering each of the 
groups being studied. Therefore allocation is not influenced by the clinicians, researchers or even 
patient persuasion.  
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This study was carried out as a pilot or it could be defined as a feasibility study. This type of study 
is a smaller version of a trial that is designed to test the logistics and gather information prior to 
a full scale project. A pilot or feasibility study can highlight any potential problems before a larger 
scale study is set up. They are usually smaller in comparison and they therefore can only provide 
limited information. This means that a pilot study alone cannot alone provide adequate data on 
variability for a power analysis to estimate the accurate number of participants needed. This was 
highlighted in this study, due to the small numbers recruited; an accurate sample size was unable 
to be calculated. 
Although an accurate sample size for future studies was unable to be calculated, the pilot study 
was invaluable in finding out if this trial was viable. It gave the researcher insight into the 
workings of a study of this kind and find out if any aspect needed to be improved upon. This study 
highlighted that this study had no patient recruitment issues and all patients were willing to 
participate. It also showed that the clinicians complied with data collection and no patients had 
to be excluded due to incomplete data. However, a few difficulties were highlighted including 
getting sufficient patient numbers and getting all of the clinicians in the department to 
participate. These will be discussed at length. 
Reporting of an RCT can be varied and the published results may be a short tailed version of the 
information required to fully interpret the results. In 1996, an international group of clinical 
epidemiologists, biostatisticians, and journal editors published a statement called CONSORT 
(Consolidation of the Standards of Reporting Trials) (Begg et al, 1996). The aim of this statement 
was to improve the standards of written reports of RCTs and to ensure that the readers find all 
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the information that they require to interpret the results correctly and with confidence. This 
statement included a checklist of 21 items and a flow diagram that should be adopted by authors 
to show the flow of the participants through the study from the start of the recruitment to the 
conclusion of the study. There was an update to this in 2010 (Schultz et al, 2010) and they also 
produced a 25 point checklist for reporting of a RCT. It provides the researcher teams a 
framework to avoid omitting important information at the point of producing the final report. It 
also an aid of producing a clear and adept report that allows the reader ease of digesting all of 
the information.  
6.2Results 
In total 9 patients were analysed for the trial. 
6.2.1Gender 
From Table 1 it can be seen that the recruited sample is primarily female at 66.6% compared to 
males at 33.3%. Females were shown to have a higher success rate than males with four females 
being successful across both groups compared to one male (table 4). These results were not 
tested for significance due to the small sample size. 
The results were similar to other studies which have shown that females have a greater uptake 
to orthodontics than male patients (Banks et al, 1988; Roberts et al, 1989). This could be related 
to more female patients presenting themselves for and seeking out treatment in comparison to 
their male counterparts. Table 4 illustrates the success rate for both Group A and Group B, and 
it can be seen that patients that were successful in group A were all female and for group B two 
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thirds of the successful patients were female. Conversely, it showed that all the males in Group 
A were unsuccessful and the unsuccessful patients in Group B were female. 
6.2.2 Pre-treatment overjet 
In table 4 the average pre-treatment overjet for Group A and Group B has been summarised. In 
Group A the average overjet was 7.1 mm and this is further broken down into the successful and 
unsuccessful patients. The average overjet of the successful patients was 7.3 mm and 7 mm for 
the unsuccessful patients.  
The average overjet in Group B was 10.5 mm. The average overjet of the successful patients was 
11.3 mm and 9.3 mm for the unsuccessful patients. 
These results may suggest that there may be an association with increased overjet and 
compliance, with the patients who present with a larger pre-treatment overjet being more likely 
to be successful with treatment. Further investigation of this would be needed to confirm this 
statistically. A possible explanation could be that patients with a very large overjet may be more 
aesthetically aware of the position of the prominent teeth and then will be more likely to comply 
with treatment. Whereas patients who have a smaller overjet may have less of a cosmetic 
concern and therefore have less motivation to wear the functional appliance. A functional 
appliance often affects a patient’s speech and mastication at the beginning of treatment and can 
be very uncomfortable to wear.  
In Table 1, the pre-treatment overjet in relation to the total sample was summarised. The 
majority of the total sample, 8 patients (89%) had an overjet within 6-12 mm. There was only 1 
patient (11%) who had an overjet of 15 mm or above. 
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In Group A all the patients had an overjet within 6-10 mm; where as in Group B, 3 patients (60%) 
had an overjet over 10 mm. 
It was perhaps unsurprising to find most patients presenting with average increased overjet 
between 6-12 mm and only one patient with a 15 mm overjet.  No patients had an overjet less 
than 6 mm, this was to be expected as patients who were in need of the proposed treatment. 
When looking at the total sample, it appears that Group B distribution of overjet was skewed in 
favour of patients who started with a higher pre-treatment overjet. This was evident as in Group 
A all the patients had an overjet within 6-10 mm, in contrast to  Group B, where 3 patients (60%) 
had an overjet over 10 mm. As this was only a small sample, it is difficult to draw any firm 
conclusions on this and it may not have been the case if a larger sample was achieved allowing 
both groups to have a more even distribution. If future studies were to be carried out it may be 
something that should be stratified for when carrying out the randomisation process to ensure 
that there is a similar range of overjet presents in each group. This would lead to an increase in 
sample size needed in an already limited population of patients that would be suitable for 
inclusion to the trial. 
The overjet characteristics of Group A displayed in table 4, show the number of successful and 
unsuccessful patients in relation to their pre-treatment overjet. In Group A all the successful 
patients had an overjet between 6-8 mm and the unsuccessful patients had an overjet between 
6-10 mm.  This could suggest that in Group A that both the successful and unsuccessful patients 
had a similar overjet and it was not a factor in success. Although due to the small sample size, 
firm conclusions cannot be drawn on this. 
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In contrast to Group A, table 4 also shows the number of successful and not successful patients 
in Group B in relation to their pre-treatment overjet. In group B, the successful patients appeared 
to have a higher pre-treatment overjet than the unsuccessful patients. As discussed earlier this 
could be due to the patients who had a larger pre-treatment overjet were more inclined to 
comply with treatment. 
6.2.3 Casuals appointments, Unable to attend (UTAs) and failure to attend (FTAs) 
Casual appointments 
It can be seen from table 2, that in the total sample there were 6 patients who attended an extra 
casual appointment out with their routine appointment. The reasons cited for attending these 
appointments were commonly an orthodontic bracket that had debonded a piece of wire causing 
buccal trauma and the appliance ‘not fitting properly’. 
In Group A, 1 successful and 1 unsuccessful patient attended the casual clinic. In Group B, 3 
successful and 1 unsuccessful patients attended the casuals’ clinic (table 4). 
More patients who were in Group B attended casual appointment compared to Group A which 
could be explained by the method of transition. Group B had no transition and therefore 
treatment continued straight into fixed appliances which was perhaps unfamiliar to them. The 
fixed appliances differ greatly from the functional appliance that the patient had previous worn 
and was familiar with, they cannot be removed and they are attached directly to each individual 
tooth with a bracket. A wire is then attached to this bracket with an elastomeric module, this 
interaction with the bracket and wire causes the tooth movement. As the appliance is bonded 
directly on to the tooth it can be debonded if the patient does not adhere to the dietary 
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instructions. One of the other reasons cited for attending the casual appointment was that the 
wire was digging into the buccal mucosa causing trauma. This is a very common presentation in 
the casual clinic as even the smallest protruding piece of wire can cause the patient discomfort.  
Therefore it could be hypothesised that because the fixed appliance was new to the patient and 
differed from previous appliance that they would have been more likely to attend the casuals 
clinic that a patient in group A who had the same familiar appliance to them. 
6.2.4 UTAs and FTAs 
From table 2 it can be seen that in the total sample only 1 patient cancelled an appointment, this 
appointment was subsequently rearranged for within 2 weeks of original date.  The one patient 
who cancelled the appointment was from Group B and did not affect the treatment outcome as 
they were successful at retaining their overjet. 
Table 2 highlighted that in the total sample only 1 patient failed to attend an appointment. The 
patient was then sent out another appointment following the protocol. The patient cited that 
they ‘forgot about the appointment’ as the reasons for failing to attend. The patient was 
accommodated within 2 weeks of original appointment. 
These very low rates of UTAs and FTAs could be explained by the patients being motivated and 
enthusiastic enough to want to participate in the clinical trial. This has been previously described 
in the medical and dental literature as the Hawthorne effect. As it has never really been proven, 
it cannot be measured or accounted. The expectation that has been previously put forward by 
researchers is that a well-designed RCT with a control group should suffer the Hawthorne effect 
(Mayo, 1949) equally in the intervention and control groups and effectively cancel itself out. 
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6.3 IOTN  
The Index of Treatment Need (IOTN) was developed in the UK in 1989 (Brook and Shaw, 1989), 
where the majority of the orthodontic patients have been treated under the National Health 
Service (NHS) since 1948.  As with any publicly-funded limited resource system, this 
epidemiological tool has been converted into a method of prioritising treatment provision in the 
primary care sector.  
It was based on the Swedish National board for Welfare Index developed by Linder-Aronson 
(1974). It defined the need for treatment in both terms of the dental health benefit and aesthetic 
handicapping.  
The index is divided into two components, the Dental Health Component (DHC) and the Aesthetic 
Component (AC). The DHC is comprised five categories of increasing treatment need of severity 
of malocclusion, from Grade 1 (no need) to Grade 5 (great need) for treatment. There are a 
number of different features of malocclusion that are scored, these features are Missing teeth, 
Overjet, Crossbites, Displacement of contact points (crowding) and Overbite. The DHC is 
hierarchical and for each individual patient the highest score is found and recorded, irrespective 
of any other features on the list that the patient may have. The grades one to five are further sub 
divided using letters which correspond to the feature of the malocclusion that has been scored. 
The AC is based on a series of ten photographs, which show a gradual worsening of dental 
aesthetics. The patient is then given a score from one to ten based on the perceived aesthetic 
impairment of the individual malocclusion, not the morphological similarities. Only the patient’s 
frontal dental view is analysed and the rest of the aesthetics of the face and smile are not taken 
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into account, which could be a limitation of the aesthetic component. It is also very subjective as 
different clinicians may perceive different malocclusion traits as worse than others and that 
would mean that patients may score differently between clinicians, another shortfall of this 
component. 
Table 1 displays the IOTN of the sample. All patients in the study had a DHC of either a 4a or 5a. 
A 4a is an overjet of 6.1 mm or above but less than 9 mm and a 5a is an overjet greater than or 
equal to 9 mm. 
In group A, all patients fell into the 4a category. In group B, two patients were a 4a and three 5a. 
This small sample is representative of what could be expected to see in patients in the Hospital 
service functional appliance treatment list. It again reinforced the findings that the patients in 
Group B had a larger pre-treatment overjet than Group A, as 3 patients had an overjet greater 
than 9 mm (5a). There were no patients in Group A that fitted into the 5a category.  
6.4 Primary outcome data 
The primary outcome of the study was the presence or absence of a corrected overjet at the end 
of the study within 2 mm of the overjet at the end of functional appliance therapy. 
From the results in table 3, it can be seen that in total in both groups, 5 patients (55.6%) were 
successful in maintaining the corrected overjet after the Twin Block therapy. 
In Group A, both the number of patients who succeeded and the number of patients who were 
unsuccessful equal.  
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In Group B, 3 (60%) patients were successful in maintaining the corrected overjet after the Twin-
block therapy and 2 (40%) patients were unsuccessful. 
A Fisher’s exact test was carried out to compare the proportions with retention of the corrected 
overjet. The p value was 0.643 (Appendix 1) which was substantially higher than the 0.05 level of 
statistical significance set for this study. 
Due to the small sample size, the study was not powered to detect the clinical significance 
difference between the groups and therefore it was not possible to determine if the intervention 
is better at maintaining the control group than the standard care group. 
This pilot did not give sufficient information to accurately estimate the proportion of successful 
retention of the overjet in the transition group. If a new study was designed to detect a minimum 
clinically difference of 20 percentage points (40% success in transition group vs. 60% in no 
transition group), a sample size of 97 patients per group would be required to detect the 
difference with 80% power at the 5% significant level. This is the highest sample size that would 
be required for a difference of 20 percentage points. If a more accurate estimate of the 
proportion in the transition group was available, this required sample size may reduce. 
Due to logistical difficulties of recruiting 97 patients per group, there may be a need to alter the 
clinical and statistical parameters of a future study. This could help reduce the patient numbers, 
albeit diminish the usefulness of the clinical data. These could be: 
1. Increase the cut off point for determining success or failure. The cut-off point in this 
project was set to 2 mm; this could be increased to 3 or 4 mm instead. The foreseeable 
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issue with increasing this figure would be that there some of the cases would be partially 
treated and therefore in contradiction to the inclusion criteria as set in the beginning of 
the study.  
2. Recruit from multiple treatment centres. A larger number of treatment centres would 
reduce the average number of patients per centre, which could be easier to recruit. This 
would be implementable in a health service with unlimited funds; in the current economic 
climate it may be difficult to justify the resources that would be required to undertake 
this. 
3. Reducing the clinical significance to less than 20% difference between intervention and 
control groups. However, this would make the results much less meaningful to use in 
clinical practice. 
6.5 Limitations 
There are a number of limitations with this study and they are mostly due to the small number 
of patients that were able to be recruited. As there were only a small number of results that were 
able to be analysed it does not lead to any substantial conclusions. It was also impossible to carry 
out an accurate estimation of a sample size needed to carry out a full scale trial. From our small 
sample, an imprecise calculation was carried out but this suggests that a large, possibly un-
obtainable sample of 97 patients per group was needed. This large number needed may indicate 
to that there may be no differences between the two types of intervention. 
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6.6 Recruitment 
The process and problems of recruiting patients for a Randomised Controlled Trial have been 
widely published in the medical literature (Treweek et al., 2010). It is very important for an RCT 
to recruit the sample size that has been deemed needed by statistical analysis. If this desired 
number of patients is not recruited the study may be underpowered, this may potentially lead to 
the reporting of clinically important effects as non-significant (Fletcher et al., 2012). If these 
findings are accepted as not significant, then potentially effective interventions may be 
abandoned or a delayed until other sufficiently powered trials is carried out. It is also important 
that the sample size calculations are carried out prospectively in order to make sure that the 
correct numbers of patients are recruited in order to have sufficient power to detect a statistically 
significant difference if there is one. Ultimately the success of this type of study depends on 
patient participation.  
In the medical literature it has been widely reported that there is poor uptake in recruitment in 
RCTs. There are a number of published studies that highlight how common it is to have problems 
with recruitment in relation to studies involving healthcare. It has been reported that 50% of 
healthcare RCT’s fail to recruit to their target sample size (Fletcher et al., 2012).  Multiple studies 
have indicated that recruitment is very poor; Rafferty et al (2008) found that two thirds of funded 
Trials failed to pass their recruitment target.  Toreien et al (2009) also echoed this in their review 
of all RCT’s published in July –December 2004, they found that of 133 Trials, 21% that reported 
sample size calculations failed to achieve adequate numbers at randomisation and 48% at 
outcome assessment. Studies by McDonald et al (2006) and Bower et al (2003) highlighted the 
problem of recruitment within a specified timescale. Bower suggested that less than a third of 
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primary care trials in the UK recruited the patients in the original timescale; both studies 
suggested that there is a barrier to recruitment for RCTs. 
A Cochrane review carried out by the Treweek et al (2010) wanted to quantify strategies that 
improve patient participation in RCTs. They investigated randomised and quasi-randomised trials 
that looked at ways of increasing patient recruitment. This Cochrane review found that patient 
recruitment increased when non-responders were contacted by telephone. It was also found that 
using an ‘opt-out’ clause rather than ‘opt-in’ can increase patient recruitment or an open design 
to allow patients know which allocation they are going to be receiving. These potential 
recommendations unfortunately have their disadvantages as if it is an open trial; it is there by 
definition un-blinded. This would introduce an element of bias, which then reduces the clinical 
value of the RCT findings by introducing unspecified confounding factors.   
There are a number of barriers to patient participation that have been cited in the literature that 
patients have indicated. Patients often feel that there may be additional demands on them if 
they enter a trial and it may be simpler not to participate. To try and overcome this drawback, all 
trials should be made as simple and least disrupting as possible for patients in order to improve 
recruitment. Patients may be concerned of additional financial aspects in that there may be 
additional costs if they take part as well as additional visits are needed. Although not deemed to 
be of significance in this study and therefore not implemented, travel costs have been previously 
reimbursed to encourage subjects to participate. In addition, of concern might be about 
treatment preference and as the ‘control’ group may provide unfavourable treatment outcomes. 
Their concerns were alleviated at the outset of this study and all discussions were clear and 
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transparent. The advantages and disadvantages of treatment options and the unknown 
significance of the two were discussed at length and the patients were invited to ask questions 
to clarify any aspects of treatment.  
Furthermore, the rationale for the trial was used in order to educate the patients on aim of the 
study. The patient documentation was also made to be ‘patient friendly’ as in the literature this 
has been found to have a profound effect on patient recruitment (Penn and Steer, 1990). There 
was very few technical terms used and most were expressed in layman’s terms. An example of 
using layman’s terms was the technical term ‘overjet’ was replaced with ’the gap between the 
top and bottom front teeth’. 
One of the other barriers to patient recruitment to a RCT is the recruiting clinician. This area has 
not been thoroughly investigated to find out if there are any interventions that improve clinician 
recruitment. This is one of the most important factors as a patient cannot recruit themselves and 
therefore a clinician needs to be motivated and interested to recruit patients and maintain this 
level of enthusiasm throughout the recruitment period. A Cochrane review carried out by Rendell 
et al (2007) aimed to assess the evidence for the effect of disincentives and incentives on the 
extent to which clinicians invite eligible patients to participate in RCTs of healthcare 
interventions. They were unable to include any RCTs and there was insufficient data for a full 
assessment of quality. Eleven observational studies were eventually included in this review. The 
review found that clinicians who agreed to participate because they were acquainted with the 
researchers were less likely to participate than those otherwise motivated (1 study, 2 sided 
p=0.04 Fisher’s exact test) and (Odds Ratio [OR] 0.4, 95% confidence interval [CI] 0.2-0.9, 1 study). 
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It also found that clinicians who had recruited were more likely to report some difficulties 
including ‘trials involve extra work’ (OR 92.94, 95% CI 4.54-1902.11; p≤0.01, 1 study) and ‘inviting 
patients to participate is embarrassing’ (Chi square 15.55, df -1, p ≤0.0001, 1 study). The effect 
of the need to discuss clinical uncertainty was unclear but concern that the doctor - patient 
relationship would be adversely affected by participation was a deterrent (chi square -7.25, df -
1, p=0.007, I study). Extra caution was taken to ensure that no patients were discouraged from 
participating in the study from the author’s point of view. 
It has also been found that there is a wide disparity between the number of clinicians who agree 
in principal to recruit their own patients into the trial and the number who actually actively 
recruit patients. A study by Taylor, (1994, 1995) suggested that in the year following completion 
of a survey on trials, only 35% of clinicians who had agreed to take part had recruited any 
patients. This study suggested possible reasons for this, a possible explanation being that when 
considering recruitment of a particular patient the disincentives becomes more salient, the 
incentives less attractive and or additional disincentives are encountered or anticipated. In 
another study by Benson et al (1991), it was cited that 73% of clinicians agreed with the 
statement that ‘excessive time is required for patient follow up on a study’ but surprisingly only 
26% stated this as the reason for not entering patients into RCTs. 
The recruitment process was one of the more challenging aspects of the trial. I personally 
encountered many of the barriers that I have previously discussed, suggesting that it they don’t 
only apply to the medical field but also to the dental field. It is a wide spread problem in clinical 
RCTs in all domains of healthcare where patient and clinician recruitment is needed.  
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It was very difficult to get the large number of patients needed in order to get results of any 
significance, as only a small number of the patients who enter our department each year are 
suitable for inclusion into the trial. This with the added difficulty of time constraints meant that 
the window of opportunity for recruitment of patients was very small. In retrospect, the 
recruitment period would have been better to have been longer in order to include as many 
patients as possible and thus increase the sample size.  
It was very difficult to try and recruit some of the Consultants to allow their patients to be 
included in the trial as they were initially sceptical. Their main objection was that they felt that 
they managed the transition effectively and efficiently, and through their own experiences had 
now felt that they had a clinical practice that suited them. The inclusion of the standard care 
Group A to have any form of transition was to ensure that the RCT was not restricting their clinical 
freedom completely. This alleviated the scepticism of some of the clinicians. In the end, all of the 
Consultants agreed to participate in the study and allow their patients to be recruited but as 
found in the literature only a small number of the Consultants actually recruited any of their 
patients into the clinical trial. 
The patients and parents were all willing to participate, there was no patient that declined to 
enter the study or removed themselves from it. It was designed in order to be as patient friendly 
as possible in order to make sure that they did not have to give up additional time to attend extra 
appointments in order to encourage them to enter the trial. As discussed earlier it is important 
to try to recruit as many patients as possible to ensure that the study has enough participants to 
allow any conclusions to be drawn. 
58 
 
6.7 Data collection 
During the course of this project, all the information that was needed was available. The clinicians 
who were taking the clinical measurements followed the protocol and there were no patients 
that had to be excluded due to poor data collection. 
The data that was to be collected was clinical measurements that have to been taken at every 
routine visit and this may explain why there was such excellent compliance within recording of 
the data. It caused no additional clinical time or appointments to be needed over and above the 
routine visits. A data collection form was designed in order for data collection and dissemination 
of the results to be efficient and easily blinded to ensure that the patient’s allocation remained 
unknown. It allowed the form to be separate from the rest of the patient’s clinical notes and to 
be stored securely.  
6.8 Generalisability 
Unfortunately due to the very small sample size, it has not been possible to make any general 
statements about the results or to bring them into the context of the clinical environment. The 
only part of the study that can be effectively compared is the way the trial was carried out. It was 
run in a fairly standardised way and it could have been comparable to the real life clinical 
environment .The results could have been applied if there were indeed any differences found in 
the two interventions that were tested. 
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6.9 Bias  
At present an RCT is the most efficient and ethical way of assessing clinical interventions. But it 
does not mean that they are free from all the pitfalls of other types of trial design. They can be 
flawed and have bias introduced into them. This will be discussed in this section. 
In the lay literature, bias has been defined as “opinion or feeling that strongly favours one side 
of an argument or one item in a group or series; predisposition; prejudice (Hornby, 4th edition). 
In research related to healthcare, it is defined as any factor or process that deviates the results 
or conclusions of a trial systematically away from the truth (Anderson, 1990; Owen, 1982; 
Sackett, 1979). This deviation away from the truth can cause results of a RCT to be overestimated 
or underestimated. Although it can be present in the control or intervention group it commonly 
leads to an exaggeration of the effects of the intervention being studied.  
Bias can be introduced voluntarily; however it is more likely to be introduced involuntarily. It can 
occur anywhere, from the planning at the very beginning, outcome measurements, analysis of 
the data, interpretation of the results, and the publication of the results (Sackett, 1979). Studies 
have shown that bias can occur even in the reading of trials. 
One of the single most important factors of an RCT is the potential to minimise or eliminate the 
effect of selection bias. When carried out correctly, randomisation can keep the groups as similar 
as possible to start with so that any differences that occur can be contributed to the interventions 
being investigated. No other form of study design has the ability to balance the known and 
unknown confounding factors between the groups. It is of the upmost importance that we aim 
to try to reduce the potential influence of bias in clinical studies, as the results of RCTs on a 
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sample population can then be inferred onto a wider population. If bias is not reduced then there 
is often a systematic deviation from the true value, often an over estimation of the effect of the 
intervention is seen.  
Randomisation ensures that all participants have the same chance of being selected for either 
intervention without being influenced by the clinician, researcher or the participant. There are a 
number of different methods for allocation of participants. A number of the methods that are 
described in the production of the final report are often misleadingly described a random 
allocation, when in fact they are not. A few examples of this type of ‘pseudo-random’ or ‘quasi-
random’ are allocation by date of birth, hospital number or date that they are invited to 
participate in the study. These methods do not give each patient an equal chance to enter a 
study; therefore it is not random allocation. Often these methods can be easily worked out and 
it is easy to find out which group each patient is randomly allocated to and this knowledge can 
affect recruitment of the patients into the trial. It may influence a clinician whether or not to 
enter a patient into the study as they could work out which treatment group they would be 
allocated too. This could affect the results and introduce bias (Altman, 1971; Schlutz et al., 1995). 
Theoretically, by allocation of the patients by random sequence, the baseline characteristics are 
balanced at baseline. By keeping the groups as similar as possible at the start of the study, the 
investigators will be more likely to isolate and quantify the impact that the intervention has on 
the participants and that the other factors will have minimal interference as they are present 
across the whole sample.  
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There are a number of ways that can be utilised to generate a random sequence of allocation. 
There are two golden rules that should be followed when setting up a random sequence 
generator regardless of which method itself. The allocation must be defined prior to starting, for 
example prior to flipping a coin there must be an allocation for what heads or tails stands for. 
The other important factor is that this must be continued throughout the whole of the trial. The 
most simple of methods to generate a sequence if there are only two groups is flipping a coin or 
rolling a die. There are more complex methods involving random number tables or computer 
generated sequences. 
The actual method selected is chosen by investigators, the numbers of patients allocated to each 
group will differ at any given time point. To minimise these differences, stratified or block 
randomisation can be carried out. Stratification is used to try and keep all the number of 
participants receiving each allocation as similar as possible. It is also used to keep the 
characteristics of the participants similar over the groups. The researcher must identify a factor 
or factors that are known to be related to the outcome of the study. Once the factor or factors 
have been identified then a separate block randomisation is carried out for each factor to ensure 
that the groups are balanced within each stratum. 
Bias also occurs when RCTs are being disseminated. The main source of this bias comes from 
during this period of the RCT timeline are, publication bias, country of publication bias, time lag 
bias, and potential breakthrough bias. Publication bias has been investigated and it has been 
shown that results that give a trial a positive response are more favourably published than results 
that show a negative response or no difference (Dickersin, 1990; Duley and Farrell; Rennie and 
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Flanagin, 1992). The only way to reduce this publication bias is to ensure that all RCTs are 
registered with a general body and that all results are recorded even if the results are not 
favourable. The system needs to be transparent but this is an area of great debate and this 
contentious issue will go on and on. Language bias is similar to publication bias, in that positive 
results are more likely to be published in English (Egger et al., 1997). Country of publication bias 
is when a particular country tends to only publish the results of positive studies. One of the big 
sources of bias during dissemination of reports is time lag bias. This is where the time taken to 
publish the results differs depending on the results of the trial (Ioannidis, 1991; Jadad and Rennie, 
1998; Vickers et al., 1998). It seems that positive results tend to be published quicker than their 
negative counterparts. Potential breakthrough bias is something is becoming more widespread 
in the lay literature. This type involves partial utilisation of a study’s results by the media in order 
to labour a reportable point. The accuracy of the statements that stem from the studies is, often, 
poor. Unfortunately, this type of bias has a large impact factor as the public tend to fail to 
understand that these results are often very misleading and full of bias. 
As this project is in the process being written up, the World Medical Association has updated the 
Helsinki Declaration. The 2013 version also discusses issues related to dissemination of health 
research information. That includes making sure that RCTs are registered in publicly accessible 
databases and that those databases include not positive results but also negative or inconclusive. 
This will hopefully bring to the fore front the importance of having all of the information available 
and allowing everyone to have the freedom to fully appreciate all the results. 
63 
 
In order to reduce the potential biases discussed, a number of features were incorporated into 
the design of the RCT. To eliminate selection bias, the patients were randomised by a computer 
generated sequence by a statistician. To reduce allocation bias, the allocation of the groups was 
concealed using opaque envelopes. This was carried out by people unrelated to the project and 
therefore the researchers and the clinicians recruiting the patients were also unaware of the 
sequence. The envelopes were stored in a locked drawer until a patient was recruited and the 
clinician was then handed an envelope from a sequential order. This was then opened with the 
patient in the Orthodontic Clinic. 
For this study, blocked randomisation was used which is a technique used to ensure that the 
number of participants assigned to each group is equal. The process of blocked randomisation is 
set up in blocks of a pre-determined size. The block size must be blinded from the investigator 
performing the study and, if the study is non-blinded, the block sizes should vary randomly 
(otherwise the last allocation(s) in a block would, in effect, be unconcealed). This has to be 
unknown to the investigator or it is possible to work out the sequence and therefore induce a 
form of selection bias. 
The randomisation process was stratified by consultant. The process of stratifying the 
randomisation is the technique for ensuring that an important baseline variable which could be 
a potential confounding factor is more evenly distributed between the two groups than if left to 
chance. It was decided to stratify by Consultant as it was felt that this could be an important 
baseline factor as different clinicians may carry out the transition from functional appliance to 
fixed appliances in a dissimilar manner. Each consultant was given the clinical freedom to choose 
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which form of transition was chosen for a patient if they were in the standard care group. 
Therefore by being given this clinical freedom there had the potential for a number of different 
forms of transition.  
Unfortunately, this study is open to ascertainment bias, which is when the results or conclusions 
are systematically distorted by knowledge of which intervention the patient is receiving. This bias 
can be introduced by the patient, the clinician carrying out the treatment and the investigator 
assessing or analysing the outcomes. Ideally, the best way to reduce this type of bias is to keep 
the people involved in the study unaware of the identity for as long as possible.  
Ascertainment bias can be minimised in two points in the timeline of an RCT. It can be minimised 
when the data is being actively collated and when the data is being analysed. As with all clinical 
RCTs it is often not possible to blind the clinician carrying out the procedure and the patient. In 
this case, it was not possible to blind the clinician as they would have to know what group they 
had in order to carry out the prescribed treatment. The patient would also know which group 
that they were allocated to. They would either be told that their functional appliance is being 
discontinued and they were proceeding into fixed appliance therapy or that they were keeping 
their functional appliance for a little longer. The only form of blinding that was able to be carried 
out was by the investigator, who could look at the collated data and carry out analysis without 
knowing which group had the intervention form of treatment. 
Bias can affect any part of a trial from beginning to end and it comes from all different sources. 
Hopefully, as illustrated above this study was as robust as possible, given its limitations and the 
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author was acutely aware of different types of bias and tried to ensure that they were addressed 
accordingly. 
6.10 Sample size 
When carrying out an RCT, an important part of the study is ensuring that the correct sample size 
is present in order to detect a clinically significant difference, if there is indeed one. Often it can 
be the case when a small trial shows that there is no statistically significant effect; it is assumed 
that there is no treatment effect at all. It could however be that the trial was not large enough to 
produce a significant effect. If this is the case then it has been said it should be thought of as ‘no 
evidence of benefit’ rather than ‘evidence of no benefit’. This makes a huge difference on how 
the area of interest is perceived as if there has been a small or badly designed study that shows 
‘no evidence of benefit’, and then it would be more likely to be re-investigated with 
improvements. 
Achieving the desired sample size as discussed early can be challenging. If there is a large disparity 
between the desired sample size and the actual sample size, it is better to carry out a small 
randomised study. However, these studies have to be thought of as hypothesis forming rather 
than hypothesis testing.  
In this case I carried out a feasibility study with one of the aims of the trial being to try predicting 
a sample size for a future study. Unfortunately, due to the small sample size achieved, this pilot 
did not give sufficient information to accurately estimate the proportion of successful retention 
of overjet in the transition group. If a new study was designed to detect a minimum clinically 
difference of 20 percentage points (40% success in transition group vs. 60% in no transition 
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group), a sample size of 97 patients per group would be required to detect the difference with 
80% power at the 0.05 significant level. This is the highest sample size that would be required for 
a difference of 20 percentage points. As mentioned previously, if a more accurate estimate of 
the proportion in the transition group was available, this required sample size may reduce. 
Having a sample size of 97 patients per group would not make this project suitable to be carried 
out in a single unit orthodontic department. The large sample size would make fulfilment of the 
required sample be almost impossible to obtain unless it was carried out over a number of years. 
This is because as a single department will only have around 40-50 patients suitable for functional 
appliance therapy per year if all patients are available for recruitment.  
Ideally, this study would be suitable to be carried out as a Multi-Centre Randomised Control Trial 
and this would allow a larger sample size to be easily obtained.  But this does not come without 
its difficulties. Having a study of this size would need multi centres being used for recruitment 
and this would have to be closely monitored to ensure that the standard protocol is adhered to 
and that all other procedures are being followed. It would also need a central area to which the 
data could be stored and where the allocations were kept. A trial of this scale would also be 
within multiple clinical sites and therefore need the approval of all involved and also the close 
working of all the clinical staff over the centres. There would be a larger financial implication in 
comparison to only having one unit where no further costs are incurred, as you may need to 
employ someone who is not directly involved with the study to carry out the administrative 
duties that would be needed in order to make sure it runs efficiently and is closely monitored. 
67 
 
6.11 Ethical approval and NHS research and development 
When deciding to plan a clinical trial involving patients it must go through rigorous approval as 
otherwise to ensure that the experimentation planned was not unwillingly harming the subjects 
by withholding a highly efficient treatment or asking a question previously answered in the 
literature. To have an effective project, the clinician must have true equipoise in the different 
arms of treatment being investigated. It would be thought of as un-ethical to recruit patients into 
a group that could cause them a detrimental effect to their health. But if the clinician has genuine 
uncertainty of the outcome for a patient then it becomes ethical to randomise the patient and in 
their best interest. 
As this project involved patient recruitment, it had to be sent for ethical approval prior to 
commencement of the trial. The ethics committees have a number of both clinical and lay 
members, and are guided by the declaration of Helsinki. The Declaration of Helsinki was set up 
in 1964 by the World Medical Association and the most recent update being October 2013 to 
ensure that it remains up-to-date and accommodates advances in the medical and ethical fields. 
It was developed as a statement of ethical principles for medical research involving human 
subjects. It includes principles on safe guarding research subjects, informed consent, minimising 
risk to the subject and adhering to an approved research protocol. The declaration is considered 
a fundamental document in the ethics of healthcare research. As a result of this the principles 
have been taken up by UK and international guidelines and regulations. The 2013 version also 
discusses issues related to dissemination of health research information. That includes making 
sure that RCTs are registered in publicly accessible databases and that those databases include 
not only positive results but also findings that are negative or inconclusive.  
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Applying for ethical approval to the novice researcher is a learning curve in itself. This project had 
to be sent to the local REC committee that dealt with children as our participants would be less 
than 16 years old. The ethical approval processes are set up primarily to deal with medical 
research involving studies of new drugs or new surgical techniques and hence rigorous 
investigation of these applications is needed prior to being approved for patient recruitment. 
However, as a dental based project as part of a doctoral degree this proved one of the most 
challenging aspect of the whole research experience. Even though the project was not 
introducing any new techniques but comparing different clinical effectively methods, the project 
still had to go through the same intense investigation as trialling a new drug. The ethics 
committees are primarily made up of clinicians and researchers with a medical background and 
therefore have a limited understanding of the dental projects. This can make the process even 
more difficult when the committees have no background or understanding of the project and it 
can cause delays while trying to explain about the project and the dental speciality. This research 
was carried out as part of a doctoral research within a fixed term speciality training appointment; 
timing was of critical importance in order to complete the study within the time frame. As this 
was a pilot study, this first experience of an application for ethics and this has provided an 
excellent insight into how the ethical approval process works. For future research it will hopefully 
ensure that the process is far more effective and efficient on the researcher’s behalf. 
In addition, the project have to be approved ethically it had to be approved by the NHS Research 
and Development department as it was being carried out by NHS funding. This proved to be time 
consuming and like ethical approval, it could be difficult to navigate through the process at times. 
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The project was initially approved to be carried out a 3 hospital sites within the deanery but all 
within different hospital trusts. This meant that the NHS Research and Development had to be 
approved separately for each NHS trust. This again was time restricting and also meant that some 
trusts responded quicker than other which meant that you could not proceed at the same rate 
with all departments. They also had to make sure that they were happy with the accompanying 
information leaflets, consent forms even though they were approved through the ethics process. 
Fortunately all NHS trusts were happy with all of the information leaflets and had no changes to 
be made other than their trust logo. 
The recurring theme throughout the ethical approval and NHS research and Development 
process was that it was very time consuming and it required a lot of planning and organisation. 
This was just as an important learning experience as the results of this project. Without having 
been through the processes, the researcher will not gain the experience and skills to carry with 
them for future research projects. It would also allow them to make the process more efficient 
and ensure that the project is commenced at a faster pace. 
If the whole process was to be repeated as part of a fixed term training contract, it would be 
recommended that gaining the ethical approval should be the first priority. This is the time 
consuming step and restricts the flow of the project and can have the project stagnating at one 
point with nothing else to do but wait.  
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7.0 Conclusions 
 
1. The null hypothesis could not be rejected based on the results of this study. Therefore, 
there is no evidence of a difference in using any form of transition following successful 
completion of functional appliance therapy compared to no transition. 
 
2. A secondary objective of this study was to investigate the size of sample size needed to 
appropriately power a Trial of this type. This was measured to 97 patients per group 
with α set at 80% and significance level of 0.05. 
 
3. Due to the small sample size, the study is not powered to detect a clinical significance 
difference between the groups and therefore it is not possible to determine if the 
intervention is better at maintaining the control group than the standard care group 
 
4. This pilot did not give sufficient information to accurately estimate the proportion of 
successful retention of the overjet in the transition group. 
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8.0 Future Research 
This pilot study was carried out in order to assess the feasibility of this Trial and to establish if any 
difficulties in recruitment, data collection and analysis of the data. It was used to perform sample 
size calculations in order to assess if a project of this type was of benefit to be carried out in a 
larger scale. 
The study could also be extended to follow the patients throughout treatment until completion 
of active orthodontic treatment, the treatment mechanics could then be looked at; to investigate 
if there were any differences between the two groups. Alternatively, the total length of 
treatment, the final overjet, PAR score and extraction rate could be assessed. 
 
 
 
 
 
 
 
 
 
 
 
 
72 
 
9.0 References 
Altman DG, (1971) Practical statistics for Medical Research. London, Chapman and Hall. 
Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. British Medical 
Journal, vol 313, pp. 570-571.Anderson B. (1990), Methodological errors in medical research. Oxford 
Blackwell Scientific.  
Balters W. (1964), Extrait de technique du Bionator. Rev Franc Odontostomat, vol 11, pp. 191–212. 
Balters W. (1969), Guia de la Te´ cnica del Bionator. Buenos Aires, Argentina: Editorial Mundi;:68 
Banks P A, Bowden D E J, Morse P H, Shaw W C (1988), The Consultant Orthodontic Service—1985 Survey. 
British Dental Journal vol 165, pp. 425-429. 
Baumrind, S. & Frantz, R.C. (1971), The reliability of head film measurements. 1. Landmark 
identification, American Journal of Orthodontics, vol. 60, no. 2, pp. 111-127. 
Baumrind, S. & Frantz, R.C. (1971), The reliability of head film measurements. 2. Conventional angular and 
linear measures, American Journal of Orthodontics, vol. 60, no 2, pp. 127-135. 
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup D, 
(1996),Improving the quality of reporting of randomised controlled trials- The CONSORT statement. 
Journal of American Medical Association, vol 276, pp. 7-9. 
Benson AB, III, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K. (1991), Oncologists’ reluctance 
to accrue patients onto clinical trials: an Illinois Cancer Center study. Journal of Clinical Oncology, vol 9, 
pp. 2067–2075.  
Bower P, Wilson S, Mathers N, (2003), Short Report: how often do UK primary care trials face recruitment 
delay? Family Pract vol 20, pp. 83-92. 
Brook PH, Shaw WC. (1989), The development of an index of orthodontic treatment priority. European 
Journal of. Orthodontics, vol 11, pp. 309-320.  
73 
 
Chadwick, S.M., Banks, P. and Wright, J.L., (1998), The use of myofunctional appliances in the UK: a survey 
of British orthodontists. Dental update, vol 25, no.7, pp. 302-308. 
Chen, J.Y., Will, L.A. & Niederman, R. (2002), Analysis of efficacy of functional appliances on mandibular 
growth, American Journal of Orthodontics and Dentofacial Orthopedics, vol. 122, no. 5, pp. 470-476.  
Clark, W.J. (1988), The twin block technique A functional orthopedic appliance system, American Journal 
of Orthodontics and Dentofacial Orthopedics, vol. 93, no. 1, pp. 1-18.  
Dermaut, L.R. & Aelbers, C.M. (1996), Orthopedics in orthodontics: Fiction or reality. A review of the 
literature--Part II, American Journal of Orthodontics and Dentofacial Orthopedics:  vol. 110, no. 6, pp. 667-
671. 
Dickersin K. (1997), How important is publication bias? A synthesis of available data, AIDS Educ Prev vol 
9. 
Dickersin K. (1990), The existence of publication bias and risk factors for its occurrence, Journal of 
American Medical Association, vol 263, pp. 1385-9. 
Clinical Trials, Lelia Duley and Barbara Farrell. 
Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. (1997), Language bias in 
randomised controlled trials published in English and German. Lancet, vol 350, pp. 329-9. 
Fleming, P.S., Scott, P. & DiBiase, A.T. (2007), How to manage the transition from functional to fixed 
appliances, Journal of orthodontics, vol. 34, no. 4, pp. 252-259. 
Fletcher B, Gheorghe A, Moore D, (2012), Improving the recruitment activity of clinicians in randomised 
controlled trials: a systematic review, British Medical Journal Open, 2012;2;E000496. 
DOI:10.1136/bmjopen-2.011-000496. 
Fränkel, R. (1966), The theoretical concept underlying the treatment with functional correctors. Report 
Of The Congress. European Orthodontic Society, vol 42, pp. 233-254. 
74 
 
Ghafari, J., Shofer, F.S., Jacobsson-Hunt, U., Markowitz, D.L. & Laster, L.L. (1998), Headgear versus function 
regulator in the early treatment of Class II division 1 malocclusion: a randomized clinical trial, American 
Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of 
Orthodontists, its Constituent Societies, and the American Board of Orthodontics, vol. 113, no. 1, pp. 51-
61. 
Gray M, Anderson R. (1998), A study of young people’s perceptions of their orthodontic need and their 
experience of orthodontic services. Primary dental Care, vol 5, pp. 87–93. 
Hornby AS. Oxford advanced learners dictionary of current English, 4th Edition. 
Houston, W.J.B., Maher, R.E., McElroy, D. & Sherriff, M. (1986), Sources of error in measurements from 
cephalometric radiographs, European Journal of Orthodontics, vol. 8, no. 3, pp. 149-151. 
Ioannidis JPA. (1991), Effect of the statistical difference of results on the time to completion and 
publication of randomised efficacy trials: a survival analysis, Journal of American Medical Association, vol 
279, pp. 281-6.  
Jadad AR, Rennie D. (1998), The randomised Controlled trial gets a middle aged check up, Journal of 
American Medical Association, vol 279, pp.319-20. 
Keeling, S.D., Wheeler, T.T., King, G.J., Garvan, C.W., Cohen, D.A., Cabassa, S., McGorray, S.P. & Taylor, 
M.G. (1998), Anteroposterior skeletal and dental changes after early Class II treatment with bionators and 
headgear, American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the 
American Association of Orthodontists, its Constituent Societies, and the American Board of 
Orthodontics, vol. 113, no. 1, pp. 40-50. 
Kingsley, N., Oral deformaties,1880, New York; Appleton and sons. 
Lahti S, Tuutti H, Hausen H, Kaariainen,R (1995), Comparison of ideal and actual behaviour of patients and 
dentists during dental treatment. Community Dent Oral Epidemiology, vol 23, pp.374–378. 
75 
 
Linder-Aronson S, (1974), Orthodontics in the Swedish Public Dental Health System, Transactions of the 
European Orthodontic Society, pp. 233-240. 
Lund, D.I. & Sandler, P.J. (1998), The effects of Twin Blocks: a prospective controlled study, American 
Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of 
Orthodontists, its Constituent Societies, and the American Board of Orthodontics, vol. 113, no. 1, pp. 104-
110.  
Elton Mayo (1949), Hawthorne and the Western Electric Company. The Social Problems of an Industrial 
Civilisation. Routledge, pp. 161-170. 
Medical Research Council. (1948), Streptomycin in Tuberculosis trials Committee. Streptomycin treatment 
of pulmonary tuberculous. British Medical Journal, pp. 769-82. 
Meikle, M.C. (2007), Remodelling the dentofacial skeleton: The biological basis of orthodontics and 
dentofacial orthopedics, Journal of Dental Research, vol. 86, no. 1, pp. 12-24.  
Miller C. (2013), Audit of failure to attend and breakages at Liverpool University Dental Hospital.  
Mills, C.M. & McCulloch, K.J. (1998), Treatment effects of the twin block appliance: a cephalometric study, 
American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American 
Association of Orthodontists, its Constituent Societies, and the American Board of Orthodontics, vol. 114, 
no. 1, pp. 15-24.  
McDonald AM, Knight RC, Campbell MK. (2006), What influences recruitment to randomised controlled 
trials? A review of trials funded by two UK funding agencies, Trials, vol 7, no.9. 
Oakley A. (2000), Experiments in knowing: gender and method in the social sciences, Cambridge Policy 
Press.  
O'Brien, K., Wright, J., Conboy, F., Chadwick, S., Connolly, I., Cook, P., Birnie, D., Hammond, M., Harradine, 
N., Lewis, D., McDade, C., Mitchell, L., Murray, A., O'Neill, J., Read, M., Robinson, S., Roberts-Harry, D., 
Sandler, J., Shaw, I. & Berk, N.W. (2003), Effectiveness of early orthodontic treatment with the twin-block 
76 
 
appliance: A multicenter, randomized, controlled trial. Part 2: Psychosocial effects, American Journal of 
Orthodontics and Dentofacial Orthopedics, vol. 124, no. 5, pp. 488-494.  
O'Brien, K., Wright, J., Conboy, F., Sanjie, Y., Mandall, N., Chadwick, S., Connolly, I., Cook, P., Birnie, D., 
Hammond, M., Harradine, N., Lewis, D., McDade, C., Mitchell, L., Murray, A., O'Neill, J., Read, M., 
Robinson, S., Roberts-Harry, D., Sandler, J. & Shaw, I. (2003), Effectiveness of early orthodontic treatment 
with the Twin-block appliance: A multicenter, randomized, controlled trial. Part 1: Dental and skeletal 
effects, American Journal of Orthodontics and Dentofacial Orthopedics, vol. 124, no. 3, pp. 234-243. 
Owen R. (1982), Reader Bias, Journal of American Medical Association, vol 247, pp. 2553-2557. 
Pancherz, H. (1979), Treatment of class II malocclusion by jumping the bite with Herbst appliance: A 
cephalometric investigation, American Journal of Orthodontics and Dentofacial Orthopedics, vol. 76, no. 
4, pp. 423-442. 
Parkin, N.A., McKeown, H.F. & Sandler, P.J. (2001), Comparison of 2 modifications of the Twin-block 
appliance in matched Class II samples, American Journal of Orthodontics and Dentofacial 
Orthopedics, vol. 119, no. 6, pp. 572-577. 
Penn ZJ, Steer PJ. (1990), Reasons for declining participation in a prospective randomised controlled trial 
to determine the optimised mode of delivery of the pre term breech,  Controlled Clinical Trials, vol 11, pp. 
226-31. 
Rabie, A.B.M., She, T.T. & Harley, V.R. (2003), Forward mandibular positioning up-regulates SOX9 and type 
II collagen expression in the glenoid fossa, Journal of Dental Research, vol. 82, no. 9, pp. 725-730. 
Raferty J, Bryant J, Powel J. (2008), Payment to healthcare professionals for patient recruitment to trials: 
systematic review and qualitative study, Health Techno Assess vol 12, pp. 1-128. 
Rendell JM, Merritt RK, Geddes J. (2007), Incentives and disincentives to participation by clinicians in 
randomised controlled trials, Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: 
MR000021. DOI: 10.1002/14651858.MR000021.pub3. 
77 
 
Rennie D, Flanagin A. (1992), Publication Bias- the triumph of hope over experience, Journal of American 
Medical Association, vol 267, pp. 411-12. 
Roberts E E, Beales J G, Dixon L, Willcocks A J, Willmot D R (1989), The orthodontic condition and 
treatment status of a sample of 14-year-old children in North Derbyshire,  Community Dental Health, vol 
6, pp. 249-256. 
Royko A, Denes Z, Razouk G. (1999), The relationship between the length of Orthodontic treatment and 
patient compliance,  Fogorv Sz. Vol 92, no 3, pp. 79-86. 
Ruf, S. & Pancherz, H. (1998), Temporomandibular joint growth adaptation in Herbst treatment: A 
prospective magnetic resonance imaging and cephalometric roentgenographic study, European Journal 
of Orthodontics, vol. 20, no. 4, pp. 375-388. 
Sackett DL. (1979), Bias in analytical research, Journal of Chronic Disease, vol 32, pp. 51-63. 
Sandler, J. & DiBiase, D. (1996), The inclined biteplane-a useful tool, American Journal of Orthodontics 
and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, its 
Constituent Societies, and the American Board of Orthodontics, vol. 110, no. 4, pp. 339-350. 
Sandler, P.J. (2001), Timing of twin-block treatment in the United Kingdom, American Journal of 
Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of 
Orthodontists, its Constituent Societies, and the American Board of Orthodontics, vol. 120, no. 4, pp. 15A-
16A.  
Schmuth, G.P.F, (1983), Milestones in the development and practical applications of the functional 
appliance,  American Journal of Orthodontics and Dentofacial Orthopedics, vol. 84, pp. 48-53. 
Schultz KF, Chalmers I, Hayes RJ, Altman DG. (1995), Empirical evidence of bias: dimensions of 
methodological quality associated with estimates of treatment effect in controlled clinical trials, Journal 
of American Medical Association, vol 273, pp. 408-412. 
78 
 
Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines 
for reporting parallel group randomised trials. BMJ 2010;340:c332  
Seehra, J., Fleming, P.S. & Dibiase, A.T. (2010), Reverse Twin Block appliance for early dental Class III 
correction,  Journal of Clinical Orthodontics , vol. 44, no. 10, pp. 602-610. 
Silverman WA, Chalmers I. (1992), Sir Austin Bradford Hill: an appreciation, Controlled Clinical Trials, vol. 
13, pp. 100-105. 
Stutzmann, J. & Petrovic, A. (1979), Intrinsic regulation of the condylar cartilage growth rate, European 
Journal of Orthodontics, vol. 1, no. 1, pp. 41-54. 
Tan, SSW, Ahamad, S, Moles, D & Cunningham, SJ (2010), Picture archiving and communication systems: 
a study of reliability of orthodontic cephalometric analysis, European Journal of Orthodontics, vol 5, pp. 
537-543. 
Taylor KM. (1985), The doctor’s dilemma: physician participation in randomized clinical trials, Cancer 
Treatment Reports, vol 69, no.10, pp. 1095–1100. 
Taylor KM, Margolese RG, Soskolne CL. (1984), Physicians’ reasons for not entering eligible patients in a 
randomized clinical trial of surgery for breast cancer, New England Journal of Medicine, vol 310, no.21, 
pp. 1363–1367. 
Toerien M, Brookes ST, Metcalf C. (2009), Review of reporting of participant recruitment and retention in 
RCT’s in six major journals, Trials, vol 10, pp. 52.  
Treweek S, Mitchell E, Pitkethly M. (2010), Strategies to improve recruitment to randomised controlled 
trials, Cochrane Database Systematic Review 2010;(4):MR000013. 
Tsolakis, A.I. & Spyropoulos, M.N. (1997), An appliance designed for experimental mandibular 
hyperpropulsion in rats, European Journal of Orthodontics, vol. 19, no. 1, pp. 1-7. 
Tulloch, J.F., Phillips, C., Koch, G. & Proffit, W.R. (1997), The effect of early intervention on skeletal pattern 
in Class II malocclusion: a randomized clinical trial, American Journal of Orthodontics and Dentofacial 
79 
 
Orthopedics : Official Publication of the American Association of Orthodontists, its Constituent Societies, 
and the American Board of Orthodontics, vol. 111, no. 4, pp. 391-400. 
Vickers A, Goyal N, Harland R, Rees R. (1998), Do certain countries produce only positive results?, 
Controlled Clinical Trials, vol 19, pp. 159-166. 
Wahl, N. (2006), Orthodontics in 3 millennia. Chapter 9: Functional appliances to mid-century, American 
Journal of Orthodontics and Dentofacial Orthopedics, vol. 129, no. 6, pp. 829-833. 
Woodside, D.G., Metaxas, A. & Altuna, G. (1987), The influence of functional appliance therapy on glenoid 
fossa remodelling, American Journal of Orthodontics and Dentofacial Orthopedics, vol. 92, no. 3, pp. 181-
198. 
World Medical Association Declaration of Helsinki (1964) 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
10.0 Appendices 
10.1 Assent form 
 
 
Version 1.1 
Centre Number:  
Study Number:  
Patient Identification Number for this trial:  
 
ASSENT FORM 
 
Title of Project:  A single-blind prospective pilot Randomised Control Trial (RCT) to 
investigate the need for a transition phase following successful 
completion of functional appliance therapy 
 
Name of Researcher:  Joanna Thomson 
Please initial box  
 
1.  I confirm that I have read and understand the information sheet dated 
August 2012 (version 1.1) for the above study. I have had the opportunity 
to consider the information, ask questions and have had these answered 
satisfactorily. 
 
 
2.  I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my medical 
care or legal rights being affected. 
 
 
3.  I understand that the data collected during the study will be analysed by 
the study investigators. I give permission for these individuals to have 
access to my records. 
 
 
4.  I agree to take part in the above study. 
 
__________________________   ____________   ______________________ 
Participant       Date    Signature  
 
 
__________________________   ____________   ______________________ 
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10.2 Patient Consent form 
 
 
 
 
Name of Person     Date    Signature  
taking assent  
 
Informed Consent Form for ____________________________________] 
 
This informed consent form is for the parents of children between the ages of 10 and 15 years 
who attend clinic Liverpool University Dental Hospital for orthodontic treatment. We are asking 
those children who have had a take-in/take-out block brace to participate in our study (known as 
a single blinded randomized clinical trial) which will investigate the need for and the management 
of a waiting period before the fixed brace is put on. 
 
 
Miss Joanna Thomson 
Liverpool University 
This Informed Consent Form has two parts: 
 
 Information Sheet (to share information about the study with you) 
 Certificate of Consent (for signatures if you agree that your child may participate) 
 
 
You will be given a copy of the full Informed Consent Form 
o                             C 
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PART I: Information Sheet 
 
Introduction 
  
I am Joanna Thomson, an orthodontic trainee at Liverpool University Dental Hospital.  As part of 
my training, I am studying the need for a waiting time between your child’s take-in/take-out 
removable brace and the fitting of a fixed brace. 
 
I explain what is involved and invite you to allow your child to take part in this research. You do 
not have to decide today whether or not you are willing for your child to participate, and you can 
let us know when you have taken a decision either way. 
 
There may be some words that you do not understand.  If so, please stop me as we go through 
the information together and I will explain more fully.  If you then have any other questions, 
either myself or any other member of the orthodontic staff will be pleased to answer them. 
 
Purpose 
The purpose of this trial is to find out if we need to wait a while between removing the take-
in/take-out block brace and putting the fixed brace on your child’s teeth. At present there is no 
evidence to suggest whether there is any advantage to this. 
  
Type of Research Intervention 
One group (the control group) will undergo a waiting time, the length of which is chosen by the 
clinician, before the fixed braces are fitted. The other group (the intervention group) will have 
the fixed appliances (fixed braces) put on immediately after the first brace/s have been taken off. 
 
Participant selection 
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We are inviting your child to take part in the study as he/she is first of all undergoing what is 
known as functional appliance therapy before a second phase of treatment with fixed appliances. 
 
Voluntary Participation 
Your decision to allow your child to participate in this study is entirely voluntary.  Should you 
initially agree but later change your mind, your child will cease to take part in the study. This will 
not affect his or her treatment in the orthodontic department here in any way. 
 
Procedures 
All the methods used in this trial are routinely used in the transition phase. As we are unsure as 
to whether any particular method is better than another, we need compare the results. This 
involves putting the participating patients into randomly assigned groups. 
 
Your child will undergo routine orthodontic treatment and on all visits standard clinical 
measurements will be taken. 
 
Duration  
Your child will take part in the research project for three months and attend monthly for the 
usual routine appointments. 
 
Risks 
There are no additional risks attached to participating in this trial beyond routine orthodontic 
treatment. 
 
Discomfort 
There are no additional discomfort from taking part in this trial. 
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Confidentiality 
All information collected from this research project will remain strictly confidential and any 
information concerning your child will be stored and available to the researchers only.  Your    
child will be identified by a number only and no names will be used. Identity is thus fully protected 
and will not be shared with anyone.  
 
 
 
Sharing the results 
The results of this study will be shared with you before being made more widely available. 
Confidential information and identity will not be revealed at any stage.  The results will be 
published subsequently so that other interested clinicians may benefit from our research. 
 
Right to Refuse or Withdraw 
You do not have to agree to your child taking part in this research if you do not wish to do so. By 
refusing to allow your child to participate, your treatment or your child's treatment in this 
department will not be affected in any way.  All treatment will be carried out as initially planned.  
You may stop your child from participating in the study at any time if you so wish, without either 
you or your child losing any of your rights as a patient here. 
 
Alternatives to participating 
If you do not wish your child to take part in the research, your child will still be provided with the 
appropriate treatment within the department. 
 
Who to Contact 
You may ask questions at any time, before and during the study.  If you wish to make any enquiry 
subsequently, you may contact:  
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Miss Joanna Thomson 
Orthodontic Department, 
Liverpool University Dental Hospital, 
Pembroke Place, 
Liverpool 
joannat@liverpool.ac.uk 
 
 
 
If you feel that you have not been satisfactorily treated and wish to make a complaint, please 
contact the following: 
 
Heather Rogers 
Research Governance Manager 
Research Development & Innovation Dept. 
4th Floor Linda McCartney Centre 
Royal Liverpool & Broadgreen University Hospital Trust 
Prescot Street 
Liverpool 
L7 8XP 
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PART II: Certificate of Consent 
 
CERTIFICATE OF CONSENT 
 
 
I have been invited to allow my child to participate in this research.  
I have read the information provided, or it has been read to me.  
I have been given the opportunity to ask questions and been satisfied with the answers. 
 
I voluntarily consent for my child to take part in this study. 
 
 
 
Print Name of Participant ____________________________________________________ 
 
Print Name of Parent or Guardian _____________________________________________  
     
Signature of Parent or Guardian _______________________________________________ 
 
 
Date _______/_______/________ 
  day     month       year  
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Statement by the Researcher/Person taking consent 
 
I have accurately read out the information sheet to the parent of the potential participant, and 
to the best of my ability made sure that the person understands that the following will be done: 
 
 
1. 
 
 
2. 
 
 
3. 
 
 
I confirm that the parent was given an opportunity to ask questions about the study, and that 
all the questions asked have been answered correctly and to the best of my ability.  I confirm 
that the individual has not been coerced into giving consent, and that the consent has been 
given freely and voluntarily.  
   
  
A copy of this ICF has been given to the participant. 
 
 
Print Name of Researcher/Person taking the consent ______________________________ 
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Signature of Researcher /Person taking the consent ________________________________ 
 
 
Date _______/_______/________ 
  day     month       year 
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10.3 Patient Information Sheet for under-16-year old patients 
 
 
 
 
A single-blind prospective Randomised Control Trial (RCT) to investigate the need for a 
transition phase following successful completion of functional appliance therapy 
 
INFORMATION SHEET FOR CHILDREN UNDER 16 
 
 
We are asking you to help us in our research project.  Before you decide whether or not to take 
part, it is important that you understand what the project is about. 
 
Why are we doing this project? 
After you have finished wearing your twin-block brace to reduce the gap between your two top 
front and bottom front teeth, we put fixed braces on which you can’t take off.  We do not want 
the gap to come back between wearing the two different sorts of braces, so we have several 
ways of stopping this happening.  In this project we want to try and see which one works best. 
 
Why ask for your help? 
We need healthy young people to take part who have a large gap between their top front teeth 
and also between their bottom front teeth, and who are wearing a twin-block brace as part of 
their orthodontic treatment. 
 
Do you have to take part? 
No, you can choose to not take part. 
 
What will happen if you take part? 
We will take certain measurements of your teeth, as we do each time you attend the hospital for 
your appointments. 
 
How long will the project last? 
We will take these measurements of your teeth over 3 months, along with the other usual details 
that are part of your dental records. 
 
What if I am not happy or have a problem? 
You can stop taking part in this project at any time. Your brace treatment will continue as normal. 
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If you have any questions, feel free to ask and I will be happy to answer them. 
 
Thank you for taking time to read this 
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10.4 Data Collection Sheet 
 
Name 
DOB 
RQ No. 
 
DATE OVERJET OVERBITE MOLAR 
RELATIONSHIP 
CANINE  
RELATIONSHIP 
CENTRE 
LINES 
ORAL 
HYGIENE 
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10.5 CONSORT Guidelines 
 
 
CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic  Checklist item 
 1a Identification as a randomised trial in the title 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 
Background and 
objectives 
2a Scientific background and explanation of rationale 
2b Specific objectives or hypotheses 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons 
Participants 4a Eligibility criteria for participants 
4b Settings and locations where the data were collected 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were actually administered 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they were assessed 
6b Any changes to trial outcomes after the trial commenced, with reasons 
Sample size 7a How sample size was determined 
7b When applicable, explanation of any interim analyses and stopping guidelines 
Randomisation:   
Sequence 
generation 
8a Method used to generate the random allocation sequence 
8b Type of randomisation; details of any restriction (such as blocking and block size) 
Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence, describing any steps taken to conceal the sequence until interventions were assigned 
Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to interventions 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those assessing outcomes) and how 
11b If relevant, description of the similarity of interventions 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and were analysed for the primary outcome 
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Participant flow (a 
diagram is strongly 
recommended) 
13b For each group, losses and exclusions after randomisation, together with reasons 
Recruitment 14a Dates defining the periods of recruitment and follow-up 
14b Why the trial ended or was stopped 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was by original assigned groups 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its precision (such as 95% confidence interval) 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing pre-specified from exploratory 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 
Other information 
Registration 23 Registration number and name of trial registry 
Protocol 24 Where the full trial protocol can be accessed, if available 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for 
important clarifications on all the items. If relevant, we also recommend reading CONSORT extensions for cluster randomised 
trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-
statement.org 
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10.6 IOTN Aesthetic Component 
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10.7 IOTN Clinical Component 
 
 
 
